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Morbidity and mortality caused by aberrant metabolic profiles and subsequent disease form 
a considerable health problem world-wide.1 At present, a wealth of studies have shown an 
association between low birth weight as an indicator of poor intra uterine growth, and adult 
metabolic diseases like obesity, type 2 diabetes, hypertension, and cardiovascular incidents.2-5 
More recently, it has been found that especially the combination of small size at birth followed 
by increased catch-up growth in later life is detrimental for adult cardiovascular health.6-8 
However, despite this abundance of studies on the early origins of adult disease, unresolved 
questions still remain.
In the majority of the original publications, the focus has been on the population born at 
term. The number of subjects born preterm included is very low, and often no clear distinction 
has been made between low birth weight due to term birth small for gestational age, or due 
to preterm birth. Nevertheless, studies in subjects born preterm could provide unique and 
important information about the timing of the early origin of adult metabolic disease. The 
third trimester of gestation is a critical developmental period, and malnutrition during this 
time span has been related to reduced adult glucose tolerance in the Dutch famine studies.9 
Infants born very preterm almost invariably experience postnatal growth failure during 
this trimester ex utero, often followed by later catch-up growth.10-15 Recently, it has been 
speculated that individuals born preterm might experience similar metabolic consequences in 
adult life as term born individuals with low birth weight.16,17 This has important implications 
for population health, because the frequency of preterm birth as well as the survival rates of 
infants born very preterm are increasing, which leads to a higher proportion born prematurely 
in the population.18
As the first generation of infants surviving very preterm birth has now reached adulthood, 
we assessed the effects of both prematurity and early growth on young adult metabolic 
outcomes in the Dutch national Project On Preterm and Small-for-gestational age infants 
(POPS) cohort. In this cohort, described in more detail below, 19 year old individuals born with 
a gestational age <32 weeks in general have a lower insulin sensitivity,19 a higher prevalence 
of hypertension,20 and a reduced kidney size21 compared with the general population. Less 
growth in the early postnatal period leads to a high risk for short stature in adulthood22, 
while more growth in childhood aggravates insulin resistance after low birth weight19. 
No associations were found with the lipid profile and intima-media thickness at this age23. 
The combination of preterm birth and intrauterine growth retardation seems to contribute 
to abnormal renal function at young adult age.24 Antenatal treatment with the corticosteroid 
betamethasone was associated with reduced kidney function in preterm females only.25
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However, before remaining research questions in this field will be addressed, some specific 
methodological issues indissolubly attached to these studies deserve special attention. Although 
part of the findings described above have been confirmed in animal studies, one should 
realize that in the human all “evidence” results from epidemiological studies. Preferably these 
data arise from prospective cohort studies to avoid recall bias and inaccurateness in perinatal 
data e.g. birth weight. Yet, the effects searched for are often small and come into existence 
only a long time period after birth, while during this period life style effects are considerable 
intervening variables. This raises the need for a large study population resulting often in a 
multi-centre design. For a correct interpretation of the results, it is important to know the 
reliability of measurements between the participating centres, which can be estimated in 
different ways. Preferably this reliability should be assessed within the study population itself. 
While in this way most research questions concerning the early origins of adult disease can be 
analyzed with a straightforward approach in a classical epidemiological design with a linear 
regression model, special attention is required when the effect of both birth weight and 
subsequent postnatal growth on adult outcome are taken into account. These two effects 
can be estimated by using two separate models for the two separate research questions, but 
often these are combined in one model. In the latter situation, the regression coefficient of 
early growth will change when later-life variables are added to the model, which should be 
interpreted correctly. 
Rationale for this thesis
In this thesis first three specific methodological issues related to early origins of adult disease 
studies will be addressed. Subsequently, three questions about the effects of prenatal and 
early postnatal growth on adult health outcomes will be studied. 
In the methodological part of the thesis, we will focus on three points: 1. 
the optimal regression model for analyzing and interpreting the effect of both a. 
prenatal and postnatal growth on adult health outcomes,
the efficiency of reliability studies in a multi-centre study,b. 
the correct and clear assessment of reliability for log transformed outcomes.c. 
In the clinical part of the thesis about the effect of early growth on adult health, we 2. 
will focus on three main outcomes:
adult renal function in non-premature subjects with low birth weight,a. 
the adult metabolic syndrome and its separate components,b. 





The follow-up studies of subjects born at term described in this thesis were conducted as 
part of the Norwegian Second Nord-Trøndelag Health (HUNT-2) Study. By performing unique 
linkage with the national Norwegian birth registry a cohort could be formed of all subjects 
aged 20 to 30 years living in this Norwegian county, which has a stable and homogeneous 
Caucasian population. Subjects were born between 1976 and 1977, with birth weights 
ranging from 1000 to 5600g, mean 3500 grams. About 4.5% of them was born preterm, 
of whom 0.4% very preterm. Perinatal data were registered at birth. Assessments in the 
HUNT-2 study took place between 1995 and 1997. Among others, venous blood was 
obtained, anthropometry was performed, and blood pressure was measured. The response 
rate in this age group was 49%, with living outside the county and lack of time as the main 
reasons of not attending.26
POPS-19
The study in subjects born preterm originates from the Project On Preterm and Small-for-
gestational-age infants (POPS) 19 study. The POPS cohort comprises 94% of all live born 
infants born very preterm (< 32 gestation weeks) or with a very low birth weight (< 1500g) 
in the Netherlands in 1983 (85% of Caucasian origin). The POPS cohort has been intensely 
studied over the years with regard to physical and psychosocial outcomes. In 2002-2003 
a new follow-up assessment took place and among others anthropometry at age 19 was 
measured. The response rate was 62%, with male sex, non-Dutch origin, and low maternal 
education overrepresented in the non-response group.27
Outline of this thesis 
In chapter 2 we provide a systematic overview of the literature about the somatic growth 
of infants born (very) preterm or with a (very) low birth weight from birth until adulthood. 
The metabolic consequences in adulthood of the preterm birth are briefly discussed. We 
compare and interpret various linear regression models in the context of optimally studying 
the early origins of adult disease in chapter 3. In these models, the effects of both prenatal and 
subsequent postnatal growth are assessed and disentangled, which is important for a correct 
interpretation of the results obtained. As reliability of measurements is important especially in 
multi-center studies, we assessed the reliability of relevant anthropometric outcomes in the 
POPS cohort. In order to design such a reliability study in the most efficient way, we developed 
a method to estimate correct and more precise intra-class correlation coefficients (ICCs) by 
integrating variance components from different sources, i.e. from both the reliability study 
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and the clinical (POPS) study itself (chapter 4). While the estimation and interpretation of 
these ICCs are not changed by log transformation of the outcome variable, this is not the case 
for other important reliability measures as Bland and Altman plots with Limits of Agreement, 
and Coefficients of Variation. Therefore, in chapter 5 we provide a practical approach in 
which existing statistical methods are applied in the field of reliability in order to present easy 
interpretable indicators of reliability on the original scale. Next, in chapter 6 we report on the 
effect of low birth weight on the metabolic syndrome at young adult age in a large Norwegian 
population study. In chapter 7 the effects of low birth weight on kidney function are assessed in 
the same population, which was predominantly born at term. In chapter 8 we present the effect 
of both prenatal and early postnatal weight gain on young adult body composition in a Dutch 
population born very preterm. Finally, in chapter 9 we give a brief overview of the main findings 




 1.  Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease 
and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747-
1757.
 2.  Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from 
ischaemic heart disease. Lancet 1989; 2:577-580.
 3.  Schluchter MD. Publication bias and heterogeneity in the relationship between systolic blood 
pressure, birth weight, and catch-up growth--a meta analysis. J Hypertens 2003 Feb 1921;273-
279.
 4.  Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R, Law CM. Is birth weight related to later 
glucose and insulin metabolism?--A systematic review. Diabet Med 2003 May 1920;339-348.
 5.  Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A. Birth weight and subsequent 
risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 2007; 165:849-857.
 6.  Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in 
childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318:427-431.
 7.  Forsen T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ. Growth in utero and during childhood 
among women who develop coronary heart disease: longitudinal study. BMJ 1999; 319:1403-
1407.
 8.  Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ 1999; 
319:245-249.
 9.  Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN et al. Glucose tolerance 
in adults after prenatal exposure to famine. Lancet 1998; 351:173-177.
 10.  Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ et al. Very low birth weight outcomes 
of the National Institute of Child health and human development neonatal research network, 
January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; 
107:E1.
 11.  Bertino E, Coscia A, Mombro M, Boni L, Rossetti G, Fabris C et al. Postnatal weight increase 
and growth velocity of very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2006; 
91:F349-F356.
 12.  Hovi P, Andersson S, Eriksson JG, Jarvenpaa AL, Strang-Karlsson S, Makitie O et al. Glucose 
regulation in young adults with very low birth weight. N Engl J Med 2007; 356:2053-2063.
 13.  Trebar B, Traunecker R, Selbmann HK, Ranke MB. Growth during the first two years predicts 
pre-school height in children born with very low birth weight (VLBW): results of a study of 1,320 
children in Germany. Pediatr Res 2007; 62:209-214.
 14.  Saigal S, Stoskopf B, Streiner D, Paneth N, Pinelli J, Boyle M. Growth trajectories of extremely 
low birth weight infants from birth to young adulthood: a longitudinal, population-based study. 
Pediatr Res 2006; 60:751-758.
 15.  Bracewell MA, Hennessy EM, Wolke D, Marlow N. The EPICure study: Growth and blood pressure 
at 6 years of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2007.
 16.  Hofman PL, Regan F, Cutfield WS. Prematurity--another example of perinatal metabolic 
programming? Horm Res 2006; 66:33-39.
 17.  Irving RJ, Belton NR, Elton RA, Walker BR. Adult cardiovascular risk factors in premature babies. 
Lancet 2000; 355:2135-2136.
 18.  Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360:1489-1497.
 19.  Finken MJ, Keijzer-Veen MG, Dekker FW, Frolich M, Hille ET, Romijn JA et al. Preterm birth and 
later insulin resistance: effects of birth weight and postnatal growth in a population based 
longitudinal study from birth into adult life. Diabetologia 2006; 49:478-485.
Chapter 1
14
 20.  Keijzer-Veen MG, Finken MJ, Nauta J, Dekker FW, Hille ET, Frolich M et al. Is blood pressure 
increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-
up study in The Netherlands. Pediatrics 2005; 116:725-731.
 21.  Keijzer-Veen MG, Kleinveld HA, Lequin MH, Dekker FW, Nauta J, de Rijke YB et al. Renal function 
and size at young adult age after intrauterine growth restriction and very premature birth. Am J 
Kidney Dis 2007; 50:542-551.
 22.  Finken MJ, Dekker FW, de Zegher F, Wit JM. Long-term height gain of prematurely born children 
with neonatal growth restraint: parallellism with the growth pattern of short children born small 
for gestational age. Pediatrics 2006; 118:640-643.
 23.  Finken MJ, Inderson A, van Montfoort N, Keijzer-Veen MG, van Weert AW, Carfil N et al. Lipid 
profile and carotid intima-media thickness in a prospective cohort of very preterm subjects at age 
19 years: effects of early growth and current body composition. Pediatr Res 2006; 59:604-609.
 24.  Keijzer-Veen MG, Kleinveld HA, Lequin MH, Dekker FW, Nauta J, de Rijke YB et al. Renal function 
and size at young adult age after intrauterine growth restriction and very premature birth. Am J 
Kidney Dis 2007; 50:542-551.
 25.  Finken MJ, Keijzer-Veen MG, Dekker FW, Frolich M, Walther FJ, Romijn JA et al. Antenatal 
glucocorticoid treatment is not associated with long-term metabolic risks in individuals born 
before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed 2008.
 26.  Holmen J, Midthjell K, Krüger Ø., Langhammer A., Holmen T.L., Bratberg G.H. et al. The Nord-
Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation. 
Norsk Epidemiologi 2003 2006; 13:19-32.
 27.  Hille ET, Elbertse L, Gravenhorst JB, Brand R, Verloove-Vanhorick SP. Nonresponse bias in a follow-




Growth of preterm born children
A.M. Euser  
C.C. de Wit  
M.J.J. Finken  
M. Rijken  
J.M. Wit 
A.M. Euser and C.C. de Wit contributed equally to this work.





In this review, we describe the growth of (very) preterm infants or (very) low-birth-weight 
infants from birth until adulthood. 
Methods
A systematic analysis of growth of these infants is thwarted by different definitions 
(classification by gestational age or birth weight) used in the literature.
Results
The early postnatal period of these individuals is almost invariably characterized by substantial 
growth failure. In the majority of preterm infants this is followed by a period of catch-up 
growth, which starts in early infancy and usually stops at 2–3 years of age, although in 
some cases it may continue into adolescence. Catch-up growth is usually incomplete, so 
that infants born preterm remain shorter and lighter than term-born peers during childhood, 
adolescence, and adulthood. Disproportionate catch-up growth in height and weight may 
lead to an altered body composition in adulthood, especially in females. 
Conclusion
Though early catch-up growth has shown to be beneficial for neurodevelopmental outcome, 
it is also associated with adverse metabolic consequences in adulthood. As the first generation 
of (very) preterm infants is now reaching young adulthood, future follow-up studies on these 
effects are warranted.
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Introduction
Based on a systematic review of the literature the definitions and determinants of prematurity, 
prenatal growth, reference charts for preterm born infants, early postnatal growth of the 
preterm infant, catch-up growth, and growth in childhood, adolescence and adulthood size 
are discussed, followed by a brief review of late metabolic consequences.
Methods
We conducted a systematic literature search in PubMed of articles published between 1998 
and October 2007. Our search strategy is shown in table 1. Relevant articles were selected on 
title and abstract. We primarily focused on original research conducted in the past 10 years in 
humans and written in English. Additional articles were sought by checking the reference lists 
of the included articles. Recent review articles that provided comprehensive overviews were 
also included. For the present paper, we selected approximately 50% of the encountered 
articles; a full list can be obtained from the authors.
Table 1.  Search strategy for PubMed
Search No.
1 ‘infant, premature’ (MeSH terms) or ‘premature infant’
(TiAb) or preterm (TiAb) or ‘infant, low birth weight’
(MeSH terms) or low birth weight (TiAb)
2 ‘growth’ (MeSH terms) or growth (TiAb)
3 growth (Ti) or ‘cohort studies’ (MeSH terms) or cohort
studies (TiAb) or cohort study (TiAb) or ‘body height’
(MeSH terms) or body height (TiAb) or ‘body weight’
(MeSH terms) or body weight (TiAb)
4 1 and 2 and 3
5 4 limits: publication date from 1998, humans
Definitions
Preterm birth is defined by the estimated gestational age as a proxy of maturity. Three 
subgroups are distinguished by the World Health Organisation (WHO): preterm (< 37 weeks 
gestation), very preterm (< 32 weeks), and extremely preterm (< 28 weeks).1 In the United 
States of America and several other countries a classification according to birth weight is 
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generally used. Low birth weight infants are defined as those with a birth weight of 2,500 g 
or less, which may be due to prematurity, being born small for gestational age (SGA), or both. 
Similarly, lower cut-off limits for weight have been used to describe more severe cases, i.e. very 
low birth weight (VLBW < 1,500 g)2,3 and extremely low birth weight (ELWB < 1,000 g).4 In 
very preterm and/or VLBW infants, gestational age is a better predictor of short-term survival 
than birth weight.5 The decision about which parameter is applied to define a cohort of small 
infants has considerable consequences for the characteristics of the population studied.
Determinants of prematurity and low birth weight
Determinants of prematurity
Various risk factors have been consistently associated with premature birth, such as multiple 
pregnancy, low socioeconomic status, African-American origin, second teenage pregnancy, 
parity and past reproductive history, substance misuse, infection and hypertensive disease 
during pregnancy.6 Approximately 14% of the variation in gestational age is explained 
by maternal genetic factors, and 11% by fetal genetic factors.7 The effect of specific 
polymorphisms in the foetus, e.g. in genes encoding immunologic or haemostatic proteins, 
seems to be modest compared to maternal risk factors.8 
Determinants of a low birth weight for gestational age
The risk factors for SGA are usually divided into foetal, placental, and maternal factors, the 
latter including maternal age, height, and parity,9 for details see.10 Foetal genetic factors 
explained 31% of the normal variation in birth weight and birth length and 27% of the 
variation in head circumference; maternal genetic factors explained 22% of the variation in 
birth weight, and 19% of the variation in birth length and head circumference.7 One of the 
foetal genes involved may be insulin, as polymorphisms in its promoter are associated with 
size at birth.10 Paternally and maternally imprinted genes oppose each other in the regulation 
of foetal growth and development, illustrated by observations that genomic imprinting of 
the IGF-II gene has a considerable effect on foetoplacental development and thus delivery 
of nutrients to the foetus.10 Although the variation in birth weight may be mainly caused by 
differences in growth in the third trimester, there is recent evidence that both the growth 
trajectory of the fetus and its adaptive responses to the prenatal and postnatal environment 
may be determined as early as the period around the time of conception.11,12




At birth, the newborn can have an appropriate weight and/or length for gestational age 
(AGA), be small for gestational age in weight and/or length (SGA), or large for gestational age 
(LGA).13 Ideally, the cut-off limit for SGA should best discriminate between infants who are 
at high risk of short-term and long-term growth impairment, disease, and death, and those 
who are at a low risk.14 However, in practice there are various cut-off limits based on arbitrary 
statistical criteria. Among paediatric endocrinologists there is consensus that a birth weight 
and/or length of < –2 SDS should be the cut-off value.9,15 Neonatologists tend to use the 5th 
or 10th percentile for gestational age,16 since these cut-offs are related to later developmental 
problems. 
Within the SGA population, three subgroups can be distinguished; infants with a low weight 
but normal length for gestational age (SGA W or SWGA), infants with a low length but normal 
weight for gestational age (SGA L or SLGA), and infants with the combination of both (SGA 
LW or SLWGA).17,18 The growth patterns of the three subgroups are somewhat different17,19 
and SLWGA males have on average a poorer neurologic outcome than those born SWGA but 
not SLGA.20 
We have previously argued that the third auxological parameter that should be measured at 
birth is head circumference. SGA H or SHGA could be added to the nomenclature to indicate 
a small head circumference for gestational age,21 which is indicative for early intrauterine 
growth retardation or, in extreme cases, for a decreased biological effect of IGF-1 due to 
primary IGF-I deficiency or resistance.22 
SGA versus IUGR
Formerly, the terms SGA and intrauterine growth restriction (IUGR) were used for the same 
condition, but nowadays there is consensus that the term IUGR should be limited to the 
process of decreased intrauterine growth rate detected by – preferably several – ultrasound 
measurements.9,15 If prolonged and/or severe enough, this may lead to the delivery of an SGA 
infant. SGA refers only to the condition at birth.15,18,21 When the prenatal growth pattern is 
unknown, SGA may be regarded as a proxy for IUGR.14 
References and standards for birth size for gestational age
For the classification of prematurity, a reliable estimate of gestational age is necessary. This 
is usually performed by combining information on the last menstrual period, and early 
ultrasound assessment,2 but neither is perfectly reliable.23 It is noteworthy that according to 
international recommendations gestational age is expressed in complete weeks,24,25 while in 
the frequently used reference of Usher and McLean gestational age was calculated to the 
nearest week from the last normal menstrual period.26 In the former approach, the reference 
curves are shifted to the left by half a week, which appears irrational. 
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For the classification of SGA (or LGA) versus AGA, anthropometric data are compared with 
reference charts for gestational age. Ideally, up-to-date reference data from the same or a 
similar population are required.14 The choice of the reference population has a considerable 
impact on the classification, especially for preterm infants.27 
Currently used neonatal charts differ substantially, and there are essentially four types of 
diagrams:
(1) Most reference charts are based on the birth size of all newborns in a certain area or 
country and are presented separately for boys and girls. The American charts (by Lubchenco28,29 
and later by Usher and McLean26) are based on small samples (so that combined charts for 
males and females were prepared) and it was shown recently that both are inaccurate for use 
in current populations in the US.30 For Northern European countries the Swedish reference is 
most appropriate.24,31
(2) In some countries separate reference charts are used for primipara and multipara mothers, 
and for different ethnic groups.32
(3) Conditional, customized charts are based on various conditions with a known impact on 
birth weight weighted in a computer model in order to calculate the degree of normality.33 On 
top of adjustments for foetal sex, gestational age and parity, additional adjustments are made 
for a number of characteristics such as maternal height, weight at first antenatal clinic visit, 
ethnic group,34 maternal birth weight and birth weight of previous siblings.35 These charts are 
primarily used by obstetricians. 
(4) ‘Standard’ charts are based on intrauterine growth measurements in babies subsequently 
born at term, from which birth weight is calculated.36 While these charts have a high sensitivity 
in detecting a neonate with a growth anomaly, calculating body weight from ultrasound 
measurements leads to an inevitable loss of precision, so that many centres continue to use 
regular reference charts based on birth weight data.37
Early postnatal growth
In the first weeks of extra-uterine life, (very) preterm infants often develop cumulative energy 
and protein deficits, despite caloric and protein supplements at recommended intakes.38 Even 
with active regimens of parenteral and/or early enteral feeding,39 this causes on average a 
substantial postnatal growth failure, with growth curves that are sharply deviating from the 
reference data.40-44 
The typical growth pattern is an initial postnatal weight loss (the lowest weight is reached at 
the fourth to seventh day), followed by an early neonatal peak in growth velocity mimicking 
in utero growth rates beginning in the second week of life. Birth weight is usually regained 
in the period between the 8th to the 24th day of life, but earlier in infants with higher birth 
weights.39,40,45 Typically, VLBW infants have weights less than the 10th percentile at 36 weeks 
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postmenstrual age,42 and have an average weight at 40 weeks postmenstrual age of -2.6 
SDS.46 In cohorts based on a low birth weight, the relatively high proportion of SGA infants 
has a negative effect on growth outcome While weight is the most documented auxological 
parameter during these first weeks, also extra-uterine growth restriction with regard to length 
and head circumference is common.43 
Although preterm infants are usually lighter and shorter at 40 weeks after the last menstrual 
period than term born infants, no difference in total adiposity was found. Moreover, preterm 
infants had an altered fat distribution, with a decrease in subcutaneous fat and an increase in 
intra-abdominal adipose tissue47 At 1 year of age, still a slightly greater fat mass normalized 
for weight was found in infants born < 34 weeks of gestation.48
Factors influencing early growth
Preterm infants are often admitted to a Neonatal Intensive Care Unit (NICU), and face 
the consequences of unintended postnatal life such as respiratory distress syndrome, 
bronchopulmonary dysplasia, necrotizing enterocolitis, and infections, with concomitant 
treatment regimens of, e.g., mechanical ventilation, parenteral nutrition, and administration 
of steroids.43,49 Both illness severity and clinical practice in treatment and nutrition vary widely 
between infants and between NICUs as well.50,51 
A low birth weight and gestational age,43,44 postnatal dexamethasone,43,49 a long duration of 
respiratory support,49 pulmonary and circulatory problems,44 severity of illness,45 infections ,43,44 
NEC,43,44 and male sex43 have been negatively associated with early postnatal growth. On 
a biological level, an important mediator of the early postnatal growth in preterm infants 
may be IGF-1.52,53 Not surprisingly, a very important factor that has been positively related to 
growth in early life is caloric intake.38,49,54
Postnatal growth references
The non-physiological situation of preterm birth makes it difficult to provide appropriate 
postnatal growth references in order to distinguish postnatal growth failure from growth that 
is normal for this specific group. Separate growth references for infants with parenteral and/or 
early nutrition have been suggested,39,55 but generally the charts of birth weight, length and 
head circumference for gestational age are used. Postnatal growth failure has been defined 
as weight below the 10th centile at 36 weeks corrected gestational age,41 or as a decrease 
in z-score of 1 > 2 between birth and 36 weeks corrected gestational age.56 We have coined 
the term ‘preterm growth restraint’ (PGR) to indicate poor growth in the third trimester, either 
spent in utero (the term born SGA infant ) or ex utero (the preterm born infant with a normal 





Catch-up growth is usually defined as reaching an SD score of 1 > -2 SDS of the reference 
population,9 but in other studies a change 1 > 0.67 SD has been used as cut-off.58 Similar 
to term infants born SGA, most preterm born infants (approximately 80%) show catch-up 
growth in weight, length and head circumference after initial postnatal growth failure,59-62 
generally starting early in the first months of life and often achieved within the first 2 years of 
life.59-61,63,64 However, late catch-up growth of preterm subjects has been described throughout 
childhood61,62 and even in adolescence.65-67
It is generally considered that catch-up growth in weight, length, and particularly in head 
circumference is important for neurodevelopmental outcome.68-70 Motor impairment was less 
common if preterm infants were fed an enriched preterm formula in comparison to a regular 
term formula in the first month after birth,71 especially in males.72 However, on average 
adolescents born very preterm have decreased brain volumes compared to term controls.73
Determinants of catch-up growth
Little is known about the factors that determine if catch-up growth occurs in preterm infants 
and whether it is complete. Also for term born SGA infants these questions have not been 
fully elucidated, but birth length and target height,74 a lower serum leptin, lower birth weight, 
early weaning from the ventilator and plasma IGF-I are associated with catch-up growth in 
weight.75,76
In preterm infants early growth and genetic potential as reflected by parental height seem 
important for catchup growth in height as well, though this effect might be different for 
different durations of gestation.61,62,66,77,78 Examples of specific genetic polymorphisms that 
have both been related to increased postnatal catch-up growth in preterm infants are the 
d3-isoform polymorphism of the growth hormone receptor gene,79 and the R23K polymorphism 
in the glucocorticoid receptor gene.80
Recently, a prediction model was presented on growth of a cohort of very low birth weight 
survivors. The following factors explained height SDS at 5 years: height SDS at 1 year, mid-
parental height SDS, 1st year weight SDS, and birth weight SDS.61 We have shown that 
infants born very preterm who reach the normal range for length (1 > -2 SDS) at 3 months 
post-term display a virtually normal growth pattern in childhood, adolescence and adulthood, 
but infants who do not catch up (labelled pre-term growth restraint, PGR) show a similar 
growth pattern as term born SGA babies. In approximately 10% of them length remains 
below the –2 SDS line.64 Most studies have shown that postnatal corticosteroid treatment has 
a negative effect on postnatal catch-up,63,81,82 but others did not find such effect.60,83-85 Other 
factors that have been negatively related to later (catch-up) growth in preterm infants include 
male gender,3 medical complications,86 and being born SGA.59-62,87
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Growth and body composition
Growth in childhood
With respect to growth in early and mid-childhood, the general pattern reported is that 
despite catch-up growth (if defined by reaching a height within the normal range) and a 
steady increase in SDS or z-score for all anthropometric measurements,60,61,88 both male and 
female infants born preterm remain smaller and lighter with a smaller head circumference 
than their term-born or normal birth weight peers,61,65,77,88 particularly if they were born 
SGA59-62,87,89 (table 2, page xx). The data in table 2, collected from recent studies, however, 
indicate that there is likely to be a trend towards normal height and weight after a decrease 
in z-scores in the first years of life. Only one study reported that preterm infants born < 29 
weeks of gestation as a group reached normal weight, height, and weight for height before 
puberty.90 With regard to body composition in infancy, a reduced fat mass when normalized 
for height at age 8-12 years was observed in children born < 37 weeks of gestation.91
Growth in adolescence and adulthood
In studies describing growth of preterm infants reaching adolescence ( table 3 ), puberty has 
not always been accurately reported. This complicates a comparison between studies, as 
puberty has an important effect on growth velocity.77 Studies reporting puberty have shown no 
difference in the timing of puberty between preterm born adolescents and term controls.3,65,67 
In adolescence, upwards percentile crossing has been reported,65-67,92,93 but adolescents born 
preterm generally continue to be shorter in puberty than term born controls.65,78
N








Hack 2003 ♂3 103 <1500 g 20 -0.44  -0.35
Hack 2003 ♀3 92 <1500 g 20 -0.26  0.26
Doyle 200467 42 500-999 g 20 -0.52  +0.14
Brandt 200566 21 <1000 g, SGA* and preterm** 22.8 -1.02
Euser 2005 ♀95 216 <32 weeks 19 -0.60  -0.48
Euser 2005 ♂95 187 <32 weeks 19 -0.55 -0.41
Farooqi 200678 83 <26 weeks 11 -0.53 -0.15
Saigal 2006 ♀65 82 <1000 g 11-16 -0.59 -0.24
Saigal 2006 ♂65 65 <1000 g 11-16 -0.46 -0.53
Table 3.  Growth of preterm and LBW infants in puberty and adulthood
* SGA as defined <10th percentile for height and/or weight
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An increasing number of studies have reported data on adult height in preterm born individuals 
(table 3), but one should note that these studies only concern the very preterm and very or 
extremely low birth weight population, from which severely handicapped subjects are usually 
excluded. Growth data of individuals born preterm at a more advanced gestational age are 
scarce. Mean height of young adults born (very) preterm is shorter than that of term-born 
controls65,67,94 and than target height.65 Again, preterm infants born SGA are at higher risk of 
short stature, as only 46% of SGA-VLBW born young adults showed complete catch-up.66
Adult weight and body composition
Young adults born (very) preterm weigh less than the average population65 (6.5 and 7.1 kg for 
males and females).65 However, catch-up for weight of individuals born preterm is generally 
more pronounced than catchup in height (table 3). The mean BMI that has been reported in 
young adulthood is close to that of the reference population in most studies,65,95 but lower94 
and higher3,67 percentages of overweight have been reported, particularly in females. 
One of the cohorts that has been followed up to young adulthood is the POPS cohort, 
consisting of infants born very preterm and/or with a very low birth weight.95,96 In young 
adulthood, the average height SDS was -0.55 and -0.60 for males and females respectively, 
but BMI SDS was -0.10 and -0.17, and waist circumference SDS +0.24 for males and even 
+0.73 for females.95 This indicates that the altered fat distribution at term age noted in 
preterm born infants might persist into adulthood, which might in turn contribute to a less 
favourable cardiovascular disease risk profile.47,95
Late metabolic consequences of preterm birth
Since the original observations of Barker and collaborators,97-100 a wealth of studies have 
shown an association between low birth weight and adult metabolic diseases like obesity, 
type 2 diabetes, hypertension and cardiovascular incidents. More recently, it has been shown 
that especially the combination of small size at birth followed by increased catch-up growth 
in later life is detrimental for adult cardiovascular health.101-103 Although these findings have 
been confirmed in animal studies, one should realize that in the human all ‘evidence’ results 
from epidemiological studies. The mechanism behind these associations has remained obscure 
thus far.104,105 In the majority of the original publications, no clear distinction has been made 
between low birth weight due to term SGA or due to preterm birth, and the number of 
preterm subjects included is very low.
It has been speculated that individuals born preterm experience similar metabolic consequences 
in adult life as term born individuals with low birth weight.106,107 The third trimester is a critical 
developmental period, and malnutrition during this time span has been related to reduced 































































































































































































































































































































































































































































































































































































































































































































































experience postnatal growth failure during this time window, often followed by later catch-
up growth. Evidence for this similarity in adverse metabolic sequelae in adulthood between 
term SGA infants and infants born preterm mostly results from studies on glucose tolerance 
and blood pressure during childhood and young adulthood in preterm or VLBW survivors 
(recently reviewed by Hofman et al.106). Both in the neonatal period109 and in childhood,110,111 
individuals born (very) preterm have a decreased insulin tolerance. 
Survivors of preterm birth are still too young to allow for studying the effect on full-blown 
cardiovascular disease, and studies are limited to early markers of cardiovascular disease in 
young adulthood. In a recent study, glucose tolerance was reduced in a cohort of VLBW young 
adults,46 and in the POPS study we found that insulin sensitivity at 19 years of age in individuals 
born very preterm was particularly decreased if BMI in young adulthood was relatively high.112 
No associations were observed between early growth and intima-media thickness.113 With 
respect to blood pressure, we found an increased incidence of hypertension and borderline 
hypertension,114 in accordance with other studies,115,116 irrespective of nephrocalcinosis.117
Conclusion
Individuals born preterm usually show a substantial growth failure in the early postnatal period, 
which is usually followed by catch-up growth over 2–3 years, but a slightly lower mean adult 
height than term born peers. Although catch-up growth is beneficial for neurodevelopmental 
outcome, it might lead to adverse metabolic consequences in adulthood. Future follow-up 
studies on these effects are warranted.
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A continued controversy exists whether the assessment of the influence of low birth weight 
on adult blood pressure necessitates adjustment for adult weight in the analysis on the fetal 
origins of adult diseases hypothesis. Here we first explain the difficulty in understanding 
an adjusted multivariate regression model, and then propose another way of writing the 
regression model to make the interpretation of the separate influence of birth weight and 
changes in weight later in life more straightforward.
Study design and setting
We used a multivariate regression model containing birth weight (standard deviation score; 
SDS), and residual adult weight (SDS) to explore the effect on blood pressure (or any other 
outcome) separately. Residual adult weight was calculated as the difference between actual 
adult weight and the expected adult weight (SDS) given on a certain birth weight (SDS).
Results
The coefficients of birth weight and residual adult weight show directly the effect on the 
analyzed outcome variable.
Conclusions
We prefer to use this regression model with unexplained residuals when the adjusted variable 
is in the causal pathway in the analyses of data referring to the fetal origins of adult diseases 
hypothesis.
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Introduction
In the literature on the fetal origins hypothesis, a continued controversy exists whether 
the assessment of the influence of low birth weight on adult blood pressure necessitates 
adjustment for adult weight.1,2 The controversy was fueled by the meta-analysis of Huxley 
et al.,3 who described little or no relation between birth weight and adult blood pressure if 
unadjusted for adult weight, and implied that such adjustment might even be misleading. 
The effect of adding adult weight as a variable in the regression of blood pressure on weight 
at birth is intricate: a review by Lucas et al.4 suggested that such a regression model should 
in fact be interpreted as the influence of a change in weight between birth and adulthood 
-and no longer as the influence of birth weight. Nonetheless, the interpretation of data by 
this concept remains confusing.
Our objective here is first to explain the difficulty in understanding the adjusted regression for 
the general reader, and then to propose another way of writing the regression model to make 
the interpretation of the separate influence of birth weight and changes in weight later in life 
more straightforward. We will explain the model not only conceptually and algebraically, but 
also by an example on data from an ongoing study on the effect of birth weight on blood 
pressure. Validation of the model in future analysis is warranted.
The adjusted regression analysis
Originally the association between birth weight and adult blood pressure was analyzed mainly 
without adjustments for additional variables.5 Later, it was shown that subjects born with low 
birth weight tended to gain more weight compared with subjects born with a normal birth 
weight. Weight gain alone was also associated with an increased risk for high blood pressure. 
Therefore, adult weight was seen as a potential confounder in the analysis, and adjustment for 
it became more common.6 Some studies, however, found a significant association between 
birth weight and adult diseases only after adjustment for adult weight.7 Therefore, the need 
for a multivariate regression model incorporating the effects of both birth weight and adult 
weight seemed to be the most promising statistical approach. Still, the interpretation of what 
was achieved by this adjustment remained unclear.
Lucas et al.4 outlined the consequences of adjustment for adult weight (or length) in a 
multivariate regression analysis. They proposed using four regression models to analyze the 
data (Table 1), and stated that in the adjusted models the early and later size of the subjects 
can no longer be interpreted as stand-alone variables: adjusting early size for later size is a 
measure of change in size between the earlier and later measurement. In their terminology, 
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the early model describes the relation between early size (i.e., birth weight, or bw) and 
outcome (Y = α1 + β1Xbw). In the late model, the relation between later size (i.e., adult 
weight, or aw) and outcome is studied (Y = α2 + γ2Xaw). The combined model (adding later 
size to the early model) can be interpreted as describing the relation between change in size 
and outcome (Y = α3 + β3Xbw + γ3Xaw), as argued by Lucas et al.4 (see Table 1). Adding 
the interaction term of early and later size yields the interaction model, allowing exploration 
of whether early size affects the relation between later size and outcome (Y = α4 + β4Xbw + 
γ4Xaw + δ4XbwXaw)4. Note, however, that the changing coefficients (in size and direction) in 
the combined and the interaction models compared to the early model result in a complicated 
interpretation. Indeed, the effect of later size is codetermined by the effect of early size on 
outcome, because adult weight is determined in part by birth weight, which influences the 
coefficients in the combined model. This also implicitly assumes a quadratic relation between 
birth weight and outcome in the interaction model, at least under the assumption that birth 
weight and adult weight are linearly related (Table 1).
Table 1.  Interpretation of the multivariate regression model of Lucas et al.4 
Model description Equation
Early model, regression analysis of birth weight 
(bw) to outcome measure
Y=α1+β1Xbw
Late model, regression analysis of adult weight 
(aw) to outcome measure
Y=α2+γ2Xaw
Combined model, adding later size to early 
model
Y=α3+β3Xbw+γ3Xaw
Interaction model, adding the interaction of 
early and adult size to the combined model
Y=α4+β4Xbw+γ4Xaw+δ4(XbwXaw)
Interaction model, with subtraction of the 
means
Y=α4+β4Xbw+γ4Xaw+δ4[(Xbw- Xbw)(Xaw- Xaw)]
Variables: Xbw birth weight; Xaw adult weight; XbwXaw interaction of birth weight and adult weight; Y 
expected outcome; α intercept; β, γ and δ coefficients.
Regression models in early origins studies
39 
Which analysis meets the researcher’s concerns?
Whether later size (e.g., adult weight) is a confounder in the analysis of early size (e.g., birth 
weight) and adult diseases, such as hypertension, or is rather a factor in the causal pathway is 
an ongoing debate in the literature. Adjustment for adult weight might not be justified after 
all.1-3 Whatever the causal explanation, birth weight is positively correlated with adult weight 
and adult weight is correlated with adult blood pressure; therefore, we do first of all expect 
that any positive relation between birth weight and adult blood pressure will be attenuated 
upon adding adult weight to the model (the coefficient of birth weight will become closer 
to zero). Next, according to Lucas et al.,4 it might be those who grew more than expected 
(i.e., attained greater adult weight for a given birth weight) who would develop the higher 
blood pressures. This would reverse the already attenuated relation with birth weight into a 
negative relation.
As researchers, we remain interested in the separate contribution of birth weight (reflecting 
prebirth influences) and change in weight from birth to adulthood (reflecting early life 
influences). Thus, we want to have an estimate of both. We want first an estimate of the effect 
of birth weight alone, and second, what we really want to know is the effect of someone 
growing more in weight than would be expected from a given birth weight. In a statistical 
analysis this can be accomplished in a single model by first calculating the expected adult 
weight, or eaw, based on birth weight (Xeaw = α0 + β0Xbw), and then subtract expected 
adult weight from actual adult weight - which is in effect the calculation of a residual 
(Xres = Xaw - Xeaw) (Table 2). Adding this residual increase in weight in a regression model 
of blood pressure on birth weight has three advantages. First, it leaves the coefficient of 
birth weight unchanged (because the effect of birth weight on adult weight is already taken 
out of the residual). Second, it gives us an insight into the additional influence of growing 
more in weight than expected upon the adult blood pressure. Third, the two variables in the 
regression model (birth weight and the residual increase in weight) are now independent, 
because the residual cannot be predicted from birth weight. Therefore, the interaction model 
does not assume a quadratic relation anymore. Li et al.8 earlier described this model in the 
analyses of a Guatemalan study in which the association between prenatal and postnatal 
growth and adult body composition was studied; however, no algebraic explanation of this 
model was shown.
The proposed technique is not unique to the problems of interpreting regression in the fetal 
origins of adult diseases hypothesis. It has been used in social sciences literature under the 
name of residualized gain score.9,10
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It should be noted that algebraically the combined model of Lucas et al.4 is the same as 
the combined model using unexplained residuals (Appendix A); however, the effect of birth 
weight and residual postnatal growth is directly shown by the coefficients of the proposed 
unexplained residual regression model. In both models, for the interaction model we suggest 
to multiply not just the two variables, but first subtract the mean of that variable. In the model 
of Lucas et al.,4 this becomes (Xbw - Xbw)(Xaw - Xaw); in the proposed model this becomes 
(Xbw - Xbw)(Xres - Xres). As the mean of a residual is zero, this can be rewritten in 
(Xbw - Xbw)Xres.
Next to the model of Lucas et al.4, other simplified models are suggested to use in the analysis 
of the fetal origins of adult diseases hypothesis to measure the effect of change in weight. 
When researchers think about the problem, they often intuitively propose to subtract adult 
weight (standard deviation score; SDS) and birth weight (SDS) as a measure of change in 
weight and add this to birth weight (SDS) in a multivariate regression model. The problem 
Table 2.  Interpretation of unexplained residual regression model
Model description Equation
Early model, regression analysis of early weight to 
outcome measure
Y=α1+β1Xbw
Late unexplained residual model, regression analysis of 
residual of expected adult weight to outcome measurea
Y=α2+γ2Xres
Combined unexplained residual model, adding the 
residual of the expected adult weight to early model
Y=α3+β3Xbw+γ3Xres
Interaction unexplained residual model, adding the 
interaction the difference between birth weight and 
the mean birth weight and the difference between the 
residual and the mean residual of the expected later size 
to the combined unexplained residual modelb
Y=α4+β4Xbw+γ4Xres+δ4[(Xbw- Xbw) 
(Xres- Xres)] in which Xres is zero.
Variables: Xbw expected birth weight; Xres residual of expected adult weight, based on birth weight; 
(Xbw- Xbw)(Xres- Xres), interaction of birth weight and residual of expected adult weight; Y, expected 
outcome; α, intercept; β, γ, and δ, coefficients.
a  First, expected adult weight Xeaw is calculated, based on birth weight (α0 + β0Xbw). Then, the residual 
for expected adult weight is calculated as Xres = (Xaw - Xeaw). This leads to the equation in column 2.
b  In the interaction unexplained residual model, β1 = β3 = β4 and γ2 = γ3 = γ4. 
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with this model is the phenomenon of regression to the mean. The relative position of 
subjects with low birth weight will tend to increase and that of subjects with high birth 
weight will tend to decrease over time. This phenomenon is not present in the unexplained 
residual model, because in the calculation of adult weight residuals out of birth weight we 
force the residuals not to be related to birth weight. The coefficient of birth weight in a linear 
regression model of adult weight residuals is exactly zero (with very small confidence interval 
and a P-value of exactly 1).
Second, it has also been suggested to use population-based SD scores instead of calculating 
the residual of expected adult weight (SDS). However, the subjects studied in research 
concerning the fetal origins of adult diseases hypothesis are mostly not comparable to the 
general population, because of an overrepresentation of the low birth weight subjects. 
Subjects with low birth weight have different growing patterns. Therefore, for most studies 
it is not recommended to use population-based SD scores to calculate expected adult weight 
(SDS) and weight gain (SDS). In addition, it takes about 3 years after birth before an individual 
will track on his or her centile, especially in low birth weight infants. If the population-based 
reference standards were to be used as a measure for expected adult weight (SDS), in which 
the mean adult weight (SDS) will be zero, low birth weight (SDS) subjects will tend to have 
a negative residual for adult weight, because of their suboptimal growth. Then, the residual 
would not reflect the correct variable to answer our second question: what is the effect 
of someone growing more in weight than would be expected from a given birth weight? 
So, calculating the residual adult weight out of birth weight should be performed with the 
expected adult weight from the group of subjects that are used in the study.
Conclusion, and proposal
Algebraically, the combined model of Lucas et al.4 and our combined model with the residuals 
increase in weight can be rewritten in terms of each other, except for the situation where 
an interaction term is entered (see Appendix A). In the proposal by Lucas et al.4, however, 
one needs two separate models: first estimating the coefficient from the early model, and 
then looking at the coefficient for attained weight in the combined model (without paying 
attention to the coefficient of birth weight in that combined model, because the latter has 
become meaningless). For this reason, we prefer the proposed model with residuals because 
it permits in a more straightforward way to estimate the effect of birth weight and the 
effect of additional weight gain in a single model. We also prefer to use the interaction 
model containing the unexplained residuals, because no quadratic relation is assumed and 
because in principle all coefficients show their own effect without mutual influence (Table 2). 
Therefore, the interpretation of the model with the unexplained residuals is easier. An example 
with numerical data from an ongoing study in the Netherlands is given in Appendix B, 
including Tables B1 and B2.
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In conclusion, we prefer to use regression model with unexplained residuals when the adjusted 
variable is in the causal pathway in the analyses of data referring to the fetal origins of adult 
diseases hypothesis.
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Appendix A. Derivations
To rewrite the combination unexplained residual model in the combination model of Lucas 
et al.,4 where Y is the expected outcome; α is the intercept; β is a coefficient; Xbw is the 
birth weight; Xaw is the adult weight; Xeaw is the expected adult weight, based on early size 
(α0 + β0Xbw); and Xres is the residual of expected adult weight (Xaw - Xeaw):








To add the interaction term (Xbw - X bw)*(Xaw - Xaw) into the Lucas et al.4 model, first suppose 
that Xaw is exactly linearly related to Xbw. Then, where ε is the residual:
Xaw = α0+β0Xbw+ε
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and
Xaw = α0 + β0 Xbw
So, (Xaw - Xaw) = (α0 + β0Xbw + ε) - (α0 + β0 Xbw) 
which can be rewritten as: 
 
(Xaw - Xaw) = β0 (Xbw - Xbw) + ε
Adding this to the interaction term 
 
(Xbw - Xbw)*(Xaw - Xaw), 
the equation will be: 
 
(Xbw - Xbw)*( β0 (Xbw - Xbw) + ε)
This can be rewritten as: 
 
β0 (Xbw - Xbw)
2 + (Xbw - Xbw) * ε
Here, the quadratic relation between birth weight and outcome is shown.
To add the interaction term into the unexplained residuals model:
(Xbw - Xbw)(Xres - Xres) = (Xbw - Xbw)Xres 
In this model, Xres (the residual of expected adult weight) is independent of Xbw (birth weight). 





Example of regression analysis according to Lucas et al.4 and the unexplained residual 
model Tables B1 and B2): In a prospective study the systolic blood pressure at adult age was 
measured. Birth weight standard deviation scores (BWSDS) and adult weight standard deviation 
scores (AWSDS) were known.
In Table B1, the change in estimated coefficients is shown in both the combined as the 
interaction model, both with and without the subtractions of means, when the model of 
Lucas et al.4 is used. In the early model, birth weight (SDS) is related to blood pressure with 
a coefficient of 0.361. When adult weight (SDS) is added to the model the coefficient for 
birth weight (SDS) changed into a negative one (-0.0928). This is a result of the relation 
between birth weight (SDS) and adult weight (SDS). This change in the estimated coefficient 
is confusing for many authors; which coefficient is giving information about the relation 
between birth weight (SDS) and blood pressure?
In the combined unexplained residuals model, these estimated coefficients do not change 
(Table B2) when adult weight (SDS) is added to the model. The coefficient for birth weight and 
residual weight gain shift slightly in the interaction model in comparison with the combined 
weight residual model: probably this is due to non-exact-linear correlation between birth 
weight and weight gain.
The δ4 coefficient does not change much in our example. The reason is that Xbw is not 
related to systolic blood pressure. Therefore, the δ4 coefficient in the model of Lucas et al.4 is 
comparable to the δ4 coefficient in our model. When Xbw would be quadratically related to 
blood pressure, the δ4 coefficient would differ much in both models.
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Table B1.  Estimated coefficients in our example when the Lucas et al.4 model is used, with 
two types of interaction 
β γ δ 
Model of Lucas et al. 4 α Xbw Xaw XbwXaw
Early 122.943 (α1) -0.361 (β1)
Late 123.908 (α2) 2.069 (γ2)
Combined 123.743 (α3) -0.0928 (β3) 2.096 (γ3)
Interaction 123.771 (α4) -0.0078 (β4) 2.231 (γ4) 0.120 (δ4)
Xbw Xaw (Xbw - X bw)(Xaw - Xaw)
Interaction with subtracted 
means 123.710 (α4) -0.0766 (β4) 2.125 (γ4) 0.120 (δ4)
Variables: α, intercept; β, γ, and δ, coefficients; Xbw expected birth weight (SDS); Xaw expected adult 
weight (SDS)
Table B2.  Estimated coefficients in our example when the unexplained residual model is 
used
β γ δ 
Model unexplained residuals α Xbw Xres (Xbw - Xbw)X res
Early 122.943 (α1) 0.361 (β1)
Late 123.623 (α2) 2.096 (γ2)
Combined 123.943 (α3) 0.361 (β3) 2.096 (γ3)
Interaction 123.943 (α4) 0.361 (β4) 2.121 (γ4) 0.102 (δ4)
Variables: α intercept; β coefficient; Xbw birth weight (SDS); Xres residual of expected adult weight 
(SDS); Xres equals zero in interaction term (Xbw - Xbw)(Xres - Xres). Expected adult weight (Xeaw) = - 0.382 
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Reliability studies are frequently organized within the context of a large (multicenter) study, 
with only a small sample of subjects measured by the observers of the large study. To estimate 
interobserver reliability, data from the large study are not frequently used. In this article, the 
advantages of combining data from the reliability study and the large study to improve the 
estimation of intra-class correlation coefficients (ICCs) are highlighted.
Study design and setting
This was done within the scope of estimating fat percentages in the Project On Preterm and 
Small-for-gestational-age infants-19 (POPS-19) study and with simulations. To calculate ICCs, 
three approaches were used: (1) the classical approach using data from a reliability study only, 
(2) the combined variances approach using inter-subject variances from the POPS-19 study, 
and (3) the maximum likelihood approach using all data.
Results
The ICCs (95% confidence interval [CI]) for fat percentage calculated by the three approaches 
were 0.84 (0.57, 0.99), 0.94 (0.90, 0.97), and 0.94 (0.88, 0.97), respectively.
Conclusion
The efficient use of data by combining data from a small reliability study with the data from 
the large study itself for the calculation of ICCs will lead to more precise ICCs.
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Introduction
The reliability of clinical measurements is an important issue in the design and interpretation 
of studies. A high degree of measurement error resulting in a poor reliability generally leads 
to underestimation of the strength of the associations studied. This affects the interpretation 
of results and can even lead to erroneous negative conclusions. To compensate for a lack of 
precision, sometimes a higher number of subjects is included or more repeated measurements 
per subject are obtained, but both are associated with less efficiency or more costs. In many 
large and often multicenter studies, reliability of clinical measurements can even be lower 
because multiple observers are involved in data collection. 
Therefore, in large (multicenter) studies reliability of clinical measurements is sometimes 
assessed in special substudies to enhance the interpretation of the results of the main study. 
For example, Visser et al. studied the reliability of the Subjective Global Assessment of 
nutritional status1 in a small substudy of the large multicenter NECOSAD cohort on risk factors 
for mortality in dialysis patients2 whereas Klipstein-Grobusch et al. described the reliability 
of anthropometric measurements3 assessed in the European Prospective Investigation into 
Cancer-Potsdam Study Cohort.4 The classical approach in this situation is to perform a 
reliability study with a small, random sample of about at least 10 study participants (subjects) 
to be measured by all observers involved in the large study.5 From the measurements in these 
reliability studies, indicators of reliability, for example intra-class correlation coefficients (ICCs), 
can be estimated.6 In this approach, only data from the subjects participating in the reliability 
study are used, whereas the data from the large study are not used.
There are several methods to estimate ICCs by combining data from the reliability study and 
the large study. The first approach is to determine the interobserver and error variance in 
the reliability study and the inter-subject variance in the large study itself. This is in the line 
of Streiner and Norman who describe a formula to apply a known ICC to a different, more 
heterogenous population.7 The second approach is to combine the data from both studies 
with maximum likelihood (ML) methods.
As these approaches are not frequently used in health science literature, the aim of this article 
was to highlight the advantages of combining data from a reliability study with data from the 
large study itself for the calculation of ICCs. For this purpose, we apply existing statistics to 
a novel context. The ICCs calculated in this way will be more accurate because of using data 
directly from the population of interest and also more precise because of the larger study 
population used. We will show this in a data set of the Project On Preterm and Small-for-





The POPS-19 study is a Dutch national prospective cohort study in young adults aged 19 
years born before 32 weeks’ gestation. Among other measurements, skinfold thickness was 
measured at four regions to determine fat mass and fat distribution in 403 19 years old. 
The POPS-19 study was organized as a multicenter study with 10 research centers all over 
the country and 15 observers.8 When the POPS-19 study was started, a reliability study was 
organized with four healthy young adults who had their skinfolds measured in all 10 research 
centers by 13 out of the 15 POPS-19 observers. Due to practical circumstances (limited space 
in a small car for four people to travel about the whole country for various measurements, 
including time consuming ones), this reliability study only had a small sample size. In both 
studies, skinfold thickness measurements were performed in duplicate on the left side of the 
body at the triceps, biceps, subscapular, and iliacal regions. In the final analyses, the mean of 
each duplicate measurement was used. Fat percentage was computed from the sum of the 
four skinfolds.9 The study was approved by the medical ethics committee of all participating 
centers, and written informed consent was obtained from all participants.
Statistical analysis
Suppose that there are n subjects in the large study where each subject is measured by one 
observer. Furthermore, let J be the number of observers and I be the number of subjects in 
the reliability study. For some given variable X, we denote by Xij the measurement of the jth 
observer made on the ith subject for i = 1, …, I, j = 1, …, J. We modeled the data as
Zij = μ + αi + βj + εij               (1)
where μ is some fixed parameter, and where αi the subject effect, βj the observer effect and 
εij are independent random effects, normally distributed with mean 0 and with between-
subject variance σ2S ; interobserver variance σ
2
O  ; and error variance σ
2
E ; respectively. 













                (2)
We consider three different approaches to estimate the variance components σ2S ; σ
2
O ; and 
σ2E and ICCinter.  For all approaches logarithmical transformations of the skinfold measurements 
were performed because of the skewed distribution of errors of these variables. 
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Classical approach
In this approach, all variance components are estimated using only the data from the reliability 
study. The design of the reliability study is balanced (all subjects are measured by all observers) 
and variance components can be estimated using classical analysis of variance, which yields 
ICCs according to equation (2) and confidence intervals (CIs). See for details Shrout and Fleiss 
(formula 2, 1): ICC with random observer effect, single ratings.6
Combined variances approach
Here, σ2O and σ
2
E are estimated from the reliability study, and the inter-subject variability 
σS
2 from the multi-center data. To estimate the inter-subject variability, we estimated the 
total variance σ2T of the variable X by the variance from the data of the large study. We 
assumed that σS
2 = σT
2 - σ2O - σ
2
E. Subsequently, estimates of ICCs were obtained by 
plugging-in estimates of variance components in equation (2). Ninety-five percent CIs of these 
ICCs can be obtained using the delta method (details are given in Appendix A), but is not 
straightforward to carry out because an estimate of the covariance matrix of the estimated 
variance components is needed.
ML approach
Both data sets are pooled and ML methods are used. Combining the data of both studies 
yields a data set with (n + I) subjects, where some of the subjects in this data set are measured 
by all observers, others by only one. In fact, one can see this as a very large reliability study 
with many missing observations (because not all subjects are measured by all observers). In 
this design, variance components can be estimated using ML or restricted maximum likelihood 
(REML). We used REML, as the REML estimator is known to be in general less biased than the 
ML estimator,10 (page 66–69). This can be carried out with software for linear mixed models 
like SAS PROC mixed (SAS institute Inc., Cary, NC, USA). This yields estimates of σ2S ; σ
2
O ; 
and σ2E and of the covariance matrix of the estimates. The ICC is calculated by plugging 
these estimates into equation (2). Again 95% CI can be obtained using the delta method (see 
Appendix A).
In the Section 3, the three different approaches to the estimation of ICCs will be applied on 
the POPS-19 data. We also compare the efficiency of the different approaches in a simulation 
study using SAS version 8.2 (SAS institute Inc., Cary, NC, USA). We simulated data from 
model (1), with mean μ=0, and with variance of the subject, observer and residual effect 




E=1, respectively. This implies that the ICC = 0.80. The 
parameter values were based upon the values of the triceps skinfold in the study example 
mentioned above, in which ICCs were all around 0.80 with quite similar observer and residual 
variances. Based on the POPS-19 example, we assumed a small reliability study with 4 subjects 
measured by 10 observers and a large study with 400 subjects each measured by only one 
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observer. Data were simulated 1,000 times from this setup. Because of the small number of 
subjects in the POPS-19 reliability study, we also repeated simulations with 10, 25, and 50 
subjects in the reliability study.
Results
General characteristics of the subjects from the POPS-19 study and the reliability study are 
displayed in Table 1. On average, the four subjects of the reliability study were somewhat older, 
and had greater body mass index (BMI) and sum of skinfolds than the POPS-19 participants. 
The anthropometric characteristics of all four subjects were well in the range of the POPS-19 
participants.
Table 1.  Characteristics of the study participants; means (SD)
Characteristics POPS-19 study (n = 403) Reliability study (n = 4)
Sex (% male) 46.4 50.0
Age 19.3 (0.18) 24.6 (3.6)
   (Min, Max) (19.1, 20.0) (22.1, 30.0)
BMI (kg/m2)
Males 21.7 (3.1) 25.3 (1.5)
   (Min, Max) (14.8, 34.7) (24.3, 26.4)
Females 21.8 (3.4) 21.2 (1.5)
   (Min, Max) (15.6, 38.9) (20.2, 22.3)
Sum of four skinfolds (mm)
Males 41.2 (20.5) 81.2 (23.6)
   (Min, Max) (16.0, 130.5) (64.6, 97.9)
Females 62.2 (22.6) 70.9 (0.57)
   (Min, Max) (7.3, 149.0) (70.5, 71.3)
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The variance components, ICCs, and 95% CIs of the triceps skinfold and fat percentage are 
presented in Table 2. Due to the small estimated between-subject variance in the reliability 
study, the classical approach yields lower ICCs compared with the two other approaches. 
This effect is more pronounced for the triceps skinfold than for the fat percentage. Both 
with the combined variances approach and with the ML approach, the obtained 95% CIs 
are much smaller than estimated with the classical approach. The ML approach yields larger 
estimates of both the between observer and measurement error variance with a slightly 
larger estimated 95% CI. The other skinfold measurements and derived estimates of body 
composition showed comparable results with regard to the differences between the various 
approaches (data not shown).
Table 2.  Variance components and ICCs estimated in the POPS-19 data according to the 
various approaches







   Classical approach 0.00675 0.00249 0.00299 0.55 0.24 - 0.95
   Combined variances approach 0.0442 0.00249 0.00299 0.89 0.82 - 0.93
   REML approach 0.04151 0.00391 0.00354 0.85 0.74 - 0.91
Fat percentage
   Classical approach 22.0 2.85 1.48 0.84 0.57 - 0.99
   Combined variances approach 70.9 2.85 1.48 0.94 0.90 - 0.97
   REML approach 71.8 3.27 1.67 0.94 0.88 - 0.97
a  For all approaches, logarithmical transformations were performed because of the skewed distribution 
of errors of the variables. 
The variance components, ICCs, and 95% CIs of the triceps skinfold and fat percentage are 
presented in Table 2. Due to the small estimated between-subject variance in the reliability 
study, the classical approach yields lower ICCs compared with the two other approaches. 
This effect is more pronounced for the triceps skinfold than for the fat percentage. Both 
with the combined variances approach and with the ML approach, the obtained 95% CIs 
are much smaller than estimated with the classical approach. The ML approach yields larger 
estimates of both the between observer and measurement error variance with a slightly 
larger estimated 95% CI. The other skinfold measurements and derived estimates of body 
composition showed comparable results with regard to the differences between the various 
approaches (data not shown).
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Table 3.  Results of 1,000 simulations to compare the three estimation approaches with 






























































































































The median and (between brackets) 5th and 95th percentiles of the 1,000 estimates are given.
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The results of the simulation analyses are summarized in Table 3. When the number of subjects 
is small (I = 4), the 90% ranges of the ICCs from the combined variances and the REML 
approach are much smaller than that of the ICC estimated with the classical approach. The 
REML approach is a little more precise with a smaller 90% range compared to the combined 
variances approach. The median value of the estimated inter-subject variance as shown in 
Table 3 was 6.34, much smaller than the true value of 8.00. The median estimates of the ICCs 
were all close to the true value of 0.80.
With increasing numbers of subjects measured, the median of the estimated inter-subject 
variances comes closer to the true parameter 8.00. For both 10 and 25 subjects, the 
ICCs estimated with the combined variance approach and the REML approach still have a 
considerably smaller 90% range than those estimated with the classical approach. With 50 
subjects, this effect is less pronounced. These simulations show that using the REML approach 
with 10 subjects in the reliability study (ICC, 90%; range, 0.73–0.87) is at least as precise as 
measuring 50 subjects and using the classical approach (ICC, 90%; range, 0.70–0.87).
Discussion
In this article, two approaches are described which improve the precision of the estimation 
of ICCs in the context of a reliability study organized within a large study. These approaches 
were compared with the classical approach, that is, estimating all variance components in the 
small reliability study. With a relatively simple method, the inter-subject variance is estimated 
in the large study itself, whereas the other variance components are estimated in a reliability 
study. The other method, which is somewhat more precise, uses ML on the combined data 
from both studies.
The advantage of these approaches is that they obviate two possible shortcomings of the 
estimation of ICCs according to the classical approach. Firstly, due to chance the subjects in 
the reliability study might not form a representative sample of the subjects in the large study 
with a different inter-subject variance. This situation in which an ICC is applied to a different, 
more heterogenous population has been described by Streiner and Norman7 page 147, and 
before by Lord and Novick,11 page 130. In combined variance and ML approaches data of 
the population of interest, namely the large study, are used to estimate the inter-subject 
variability, circumventing this problem. Secondly, a relatively small number of subjects is used 
in the classical approach, whereas with our approaches in which all available data are used a 
more precise estimation can be carried out with smaller CIs as a result.
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A limitation of our study is the small sample size of four subjects we had to use in the 
reliability study due to practical circumstances. We assume that measurement error in skinfold 
thicknesses is not remarkably different in 19 and 20–30 years old, but still the small size could 
have influenced the value of the inter-subject variance found. In contrast, the interobserver 
variance was based on measurements of 13 observers. In the simulations, it can be seen that 
the estimated inter-subject variance with four subjects in the reliability study could differ 
much from the real parameter, which shows the advantages of our approaches. We studied 
the generalizibility of our results by repeating simulations with larger numbers of subjects 
as commonly used in reliability studies3, 5, 12 and.13 With 10 or 25 subjects, the inter-subject 
variance and ICC did not differ much between all approaches, but the combined variances 
approach and the REML approach are still preferable to the classical approach regarding the 
precision of the estimated ICC as reflected in the smaller 90% ranges.
For clarity, in this article we used the means of duplicate measurements, and modeled the 
data as Xij = μ + αi + βj + εij. However, the described approaches of calculating ICCs 
can also be extended to a model using the separate duplicate measurements on a subject, 
subdividing the error variance into variance due to observer–subject variance and residual 
error variance. This will give comparable results.
In conclusion, we have shown the value of our novel approaches to estimate more precise 
ICCs with the efficient use of combined data in the POPS-19 study and we suggest that 
this approach can also be used in other studies concerning the reliability of outcomes in 
a large study. It is important to have precise information about the interobserver reliability 
of the outcome measurements, because this will influence the associations found between 
determinant and outcome in the large study. Low reliability will give noise and dilution, or 
even confounding of the associations found. With our approaches more precise estimations 
of ICCs are obtained, and we suggest to take this innovation into account when designing 
future reliability studies in the context of a large study.
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Appendix A
In this appendix, it is shown how a confidence interval can be calculated for an intra class 
correlation, using the delta method. 












In the maximum likelihood approach, the variance components are estimated by either ML or 
REML, which also yields an estimate of the covariance matrix of the estimates.






































T , where the superscript T indicates a transposed vector. The delta method 
gives that
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and this can be plugged in (*) to obtain the variance of Ẑ . A 95% confidence interval for Z 
can be calculated by:
)Zvar(1.96Z),Zvar(1.96Z( ˆˆˆˆ +−
This interval can be transformed back to an interval for ICC. If lwb and upb are respectively 




































In the combined variances approach, the total variance 2Tσ  was estimated from the large 
study, while independently 2Oσ  and 
2











, the delta method can be applied in the same way to obtain confidence 
 
intervals in this situation.
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Participants of the Dutch POPS-19 Collaborative Study Group
TNO Prevention and Health, Leiden (E.T.M. Hille, C.H. de Groot, H. Kloosterboer-Boerrigter, 
A.L. den Ouden, A. Rijpstra, S.P. Verloove-Vanhorick, J.A. Vogelaar); Emma Children’s Hospital 
AMC, Amsterdam (J.H. Kok, A. Ilsen, M. van der Lans, W.J.C. Boelen-van der Loo, T. Lundqvist, 
H.S.A. Heymans); University Hospital Groningen, Beatrix Children’s Hospital, Groningen (E.J. 
Duiverman, W.B. Geven, M.L. Duiverman, L.I. Geven, E.J.L.E. Vrijlandt); University Hospital 
Maastricht, Maastricht (A.L.M. Mulder, A. Gerver); University Medical Center St Radboud, 
Nijmegen (L.A.A. Kollée, L. Reijmers, R. Sonnemans); Leiden University Medical Center, Leiden 
(J.M. Wit, F.W. Dekker, M.J.J. Finken); Erasmus MC – Sophia Children’s Hospital, University 
Medical Center Rotterdam (N. Weisglas-Kuperus, M.G. Keijzer-Veen, A.J. van der Heijden, 
J.B. van Goudoever); VU University Medical Center, Amsterdam (M.M. van Weissenbruch, A. 
Cranendonk, H.A. Delemarre-van de Waal, L. de Groot, J.F. Samsom); Wilhelmina Children’s 
Hospital, UMC, Utrecht (L.S. de Vries, K.J. Rademaker, E. Moerman, M. Voogsgeerd); Máxima 
Medical Center, Veldhoven (M.J.K. de Kleine, P. Andriessen, C.C.M. Dielissen-van Helvoirt, 
I. Mohamed); Isala Clinics, Zwolle (H.L.M. van Straaten, W. Baerts, G.W. Veneklaas Slots-
Kloosterboer, E.M.J. Tuller-Pikkemaat); Royal Effatha Guyot Group, Zoetermeer (M.H. Ens-
Dokkum); and Association for Parents of Premature Babies (G.J. van Steenbrugge).
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A practical approach to Bland-Altman plots and 










Indicators of reproducibility for log-transformed variables can often not be calculated straight-
forwardly and are subsequently incorrectly interpreted.
Methods and Results
We discuss meaningful Coefficients of Variation (CV) for log-transformed variables, which can 
be derived directly from the standard error of the log-transformed measurements. To provide 
easy interpretable Bland and Altman plots, we calculated limits of inter and intraobserver 
agreement (LA) for log-transformed variables and transform them back to the original scale. 
These LAs for agreement are subsequently plotted on the original scale in a conventional Bland 
and Altman plot. Both approaches were illustrated in a clinical example on the reproducibility 
of skinfold thickness measurements.
Conclusion
In reproducibility, it is important to calculate meaningful CVs, LAs, and Bland–Altman plots 
for log-transformed variables. We provide a practical approach in which existing statistical 
methods are applied in the field of reproducibility, thus leading to parameters of reproducibility 
which can be interpreted on the original scale.
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Introduction
Reproducibility can be described as the repeatability of measurements in time or by different 
observers.1,2 Several indicators of reproducibility are applied in literature, with Intraclass 
Correlation Coefficients (ICC), Coefficients of Variation (CV), and limits of agreement (LA) 
being most frequently used. An ICC is a relative measurement of reliability, in which variation 
due to measurement error is compared with the variation between subjects. In a CV, reliability 
is expressed as the variation between measurements in relation to the mean value of all 
measurements. In contrast, LAs provide direct information about the absolute measurement 
error, which is plotted against the mean of the two measurements in a Bland and Altman Plot. 
This agreement forms an important measurement property by itself.2
Before reproducibility can be determined, data are frequently log transformed to approximate 
normality because of a skewed distribution of errors. Although ICCs after log transformation 
can still be calculated straight forward by estimating variance components on the log 
transformed data, a problem arises with the calculation and interpretation of other indicators 
of reproducibility, both for reliability and agreement measurements. CVs calculated in 
the conventional way have no natural interpretation anymore when estimated on a log-
transformed scale without an actual zero. Bland and Altman describe the calculation of limits 
of agreement on log-transformed data.3 However, the advantage of the Bland and Altman 
plot as an easy interpretable indicator of reproducibility expressed in the absolute units of 
measurement used in the clinical situation doesn’t apply anymore.
In this article we discuss methods to calculate meaningful and interpretable CVs and LAs on 




In studies on reproducibility, one usually has observers (or instruments) measuring subjects. 
For simplicity, we start by assuming that each observer measures each subject once and focus 
on interobserver variability. Later on, we also consider the situation when more measurements 
are taken, which can be used to assess intraobserver variability. We denote the clinical 
measurement of interest by X and write Xij for the measurement of the jth observer made on 
the ith subject (i = 1,…I, j = 1,..,J).
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In this article, we consider the situation that the distribution of X is skewed and that a 
log transformation is performed to obtain an approximately normal distribution. The log-
transformed measurement is denoted by Z. Although natural logarithms are mathematically 
more convenient, we consider here the 10-log transformation, because this is the 
transformation most frequently used in the applied field: Z = 10log (X).
Random effect models
Linear random effect models are often used to analyze this kind of data. Here we assume that 
the log-transformed variable Z follows the following linear random effect model:
Zij = μ + αi + βj + εij [Model a]
where μ is some fixed parameter, and where αi, the subject effect, βj, the observer effect, 
and εij are independent random effects, normally distributed with mean 0 and with between-
subject variance σS
2, interobserver variance σO
2, and error variance σE
2, respectively. In 
studying interobserver reproducibility, the interobserver variance σO
2 and error variance σE
2 
are expressed in relationship to the between-subject variance σS
2.
Coefficient of variation
The coefficient of variation expresses the standard deviation as a percentage of the mean. It is 
a relative, unit-free measure, but it has only a useful interpretation if the measurement scale 
is positive, with value 0 the minimum value. For example, a CV for height or weight has a 
clear interpretation, but a CV for temperature measured in degrees Celsius or Fahrenheit not, 
because temperatures can be negative and the value 0 is not an absolute minimum.
When assessing the interobserver reproducibility, one would like to relate the mean of the 
observations to the spread of the measurements from different observers on the same subject. 
This measurement error between observations equals )σσ( 2E
2
O
ˆˆ + , and is sometimes called 
the agreement standard error of the measurement: SEMagreement.
2 In the linear random effects 






, with Z the 
sample mean of measurements of Z and σ indicates the estimate of σ. However, it makes 
no sense to calculate this CV for Z, since on the log scale, 0 is no absolute minimum. Values 
of X smaller than 1 correspond to values of Z smaller than 0, and it is well possible that Z is 
0 or even negative.
Therefore, CV should be defined on the original scale. It can easily be shown, using Taylor 
expansion, that the standard deviation of a naturally log-transformed variable is approximately 
equal to the CV on the original scale. Therefore the SEMagreement of the natural-log transformed 
measurement is quite commonly used as interobserver CV on the original scale. Here, we 
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ˆˆ +  is the spread of the log-transformed measurements from different observers 
on the same subject. The value ln(10) is needed since we consider 10-log transformations. 
Bland and Altman4 suggest a different CV for log-transformed variables. There are no strong 
arguments in favor of their way of calculating CVs and the two approaches will yield very 
similar results when the CV is not large.
Limits of agreement and Bland–Altman plots
Assessing agreement between two observers or measurement methods can be done by using 
Bland and Altman plots and calculating limits of agreement. In a Bland and Altman plot, the 
difference between the two measurements per subject is plotted against the mean of the 
two measurements. In our situation, we have random observers, and assume that the mean 
difference between two arbitrary observers is 0. The limits of agreement are then defined as 
−1.96 s and +1.96 s, with s the observed standard deviation of the difference between the 
two measurements per subject. If the spread of the differences increases with increasing mean 
of the observations, the Bland Altman plot and limits of agreement should be calculated on a 
log scale. This is straightforward to do, but it is difficult to interpret log-transformed variables 
in clinical practice.
We transformed these limits of agreement back to the original scale by taking anti-logs. This 
yields an interval for the ratio between two measurements. If the limits of agreement for 
Z = 10log (X) are between −a and a, with a = 1.96 s, this implies that the ratio between two 
measures on the original scale (X1/X2) is between 10−a and 10a. Then, for a given value for x , 
it can be shown that X1 - X2 is between ) 1(101)/(10Χ2
aa +−−  and ) 1(101)/(10Χ2
aa +−− . 
Although a ratio of measures is still difficult to conceptualize, these LAs on the original 
scale can be plotted in a conventional Bland and Altman plot of X to clearly visualize the 
reproducibility of the measurement for each different value of X .
So far, we considered only two observers. Rousson et al. extended the definition of limits of 





This upper limit of  is also called the smallest detectible change,2 that 
is, the smallest change in measurement, which is unlikely to occur by differences between 
observers. In the same way as described previously, the limits of agreement can be calculated 
for the log transformed variable Z and transformed back to the original scale. A Bland and 
Altman plot on the original scale of X can then be made by drawing these back transformed 
limits of agreement as function of the mean of X. An impression of the distribution of the 
individual data can be obtained by considering all possible pairs of observers and plotting the 
difference between the measurements per observer pair on the same subject versus the mean 







To assess the intraobserver reproducibility, an observer has to measure a subject more than 
one time. Let Zijk be the kth measurement of observer i on subject j. Model [a] as described 
above can be extended to:
Zijk = μ + αi + βj + γij + ε(ij)k [Model b].
The extra random term γij models interaction between observer and subject and is assumed 
to be normally distributed, with mean 0 and variance σ2OS. The residual error term ε(ij)k 
with variance σ2ER indicates the random error occurring within measurements made by one 
observer on one subject. For good intraobserver reproducibility this within-subject-observer 
variation should be as small as possible.
Following the same reasoning as described for the interreproducibility measures, for the Intra 
Coefficient of Variation of X, the CVintra= 100% x R Eσln(10) ˆ can be used.
The intra-observer limits of agreement on the log scale are:  LAintra = 
2
R E2σ1.960 ⋅± , and 
can be transformed back to limits of agreement for the difference of two measurements 
made by the same observer on the same subject Xij1-Xij2 being equal to 
) 1(101)/(10Χ2 aa +−−  and ) 1(101)/(10Χ2 aa +−− , where a = 2R E2σ1.96 ⋅  .
Clinical example
To demonstrate the advantages of the methods described above, especially for the Bland 
and Altman plots, we will show data from a clinical study on the reproducibility of skinfold 
thickness measurements in young adults. In this study, skinfold thickness measurements 
at four locations (triceps, biceps, subscapular, and iliacal) were taken in duplicate on four 
subjects by 13 observers. Every subject was measured in duplicate at the four skinfold 
locations by all 13 observers. In the estimation of interobserver reproducibility, the mean of 
the two measurements by one observer was taken for every skinfold location. The objectives 
and methods of this study are described in detail elsewhere6 and7. In this example, we take 
the data from the biceps skinfold measurement. Indicators of reproducibility and variance 
components and of the biceps skinfold measurement are displayed in Table 1. 
Coefficient of variation
At first glance, one should be tempted to apply the normal formula for calculating an interobserver 
CV on the log-transformed data and thus divide 2E
2
O σσ + = )0 17.1420 1(12.9
33 −− ⋅+⋅ = 
0.142 by the mean log-transformed biceps skinfold measurement, which is 1.14 (see Table 1). 
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Table 1.  Indicators of reproducibility of the biceps skinfold measurement
Biceps skinfold
   Mean and range of all measurements on original scale (mm) 14.5 (range 7.3–29.0)
   Mean and range of all measurements of 10log transformed variable 1.14 (range 0.86–1.46)
Variance Components of 10log transformed variable
   Intersubject variance σS
2 2.904−3
   Interobserver variance σO
2 12.90−3
   Error-variance* σE
2 7.142−3
   Observer-subject variance σOS
2 6.592−3
   Residual-error variance σER
2 1.099−3
Limits of agreement
   Intraobserver LA of 10log biceps -0.092 to 0.092
   Intraobserver LA of ratio of two biceps measurements -0.809 to 1.235
   Intraobserver LA of difference of two biceps measurements as 
   function of the mean Χ -0.21Χ to 0.21Χ
   Interobserver LA of 10log biceps -0.392 to 0.392
   Interobserver LA of ratio of two biceps measurements -0.400 to 2.499
   Interobserver LA of difference of two biceps measurements as 
   function of the mean Χ -0.85Χ to 0.85Χ
Coefficients of variation
   Intraobserver CV (%) 7.6%
   Interobserver CV (%) 33.1%
a·10−3 was written as a−3.
* In this example σE = σOS
2 + σER
2/2, since each observer measured a subject twice.
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Figure 1.  Conventional Bland and Altman plot. The differences between the first and second 
biceps skinfold measurement in relation to the mean of the two measurements of one 
observer on a subject. Lines are plotted indicating the limits of agreement (0 ± 1.96 S.D.).













































This yields an interobserver CV of 12.5%. The quantitative value of this CV might look attractive, 
but as explained above it is a completely meaningless value. Therefore, one should apply the 
formula for log-transformed data, which yields a CV of 100%ln(10) × 0.142 = 33.1%. This is 
a true, meaningful value and indicates that the interobserver reproducibility of this skinfold is 
not that good compared with other literature on this topic.8
Limits of agreement and Bland–Altman plots
As can be clearly seen in the first conventional Bland and Altman plot, (Figure 1), the 
differences between the first and second measurement of the biceps skinfold by an observer 
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Figure 2.  Bland and Altman plot of log-transformed data. The differences between the 
first and second 10 log biceps skinfold measurement in relation to the 10 log mean of the 
two measurements of one observer on a subject. Lines are plotted indicating the limits of 
agreement (0 ± 1.96 S.D.).
thickness of the biceps skinfold. Therefore, the conventional LAs do not well represent any 
of the measurements. In the second Bland and Altman plot, (Figure 2), on log-transformed 
data, the spread of observations on the left hand side is comparable to the spread on the 
right hand side. The LAs plotted do fit better, although some skewness remains.However, 
these log-transformed values are difficult to interpret for use in clinical practice. The values 
on the x and y-axis can be anti-logged, yielding the same plot but with more interpretable 
axes: geometric means on the x-axis and the ratio of measurements on the y-axis.4 
Still we prefer to study differences on the original scale and not ratios, because of their 
direct clinical interpretation. Therefore, in the third Bland and Altman plot, (Figure 3), we 
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Figure 3.  Bland and Altman plot on the original scale with back transformed limits of 
agreement. The differences between the first and second biceps skinfold measurement in 
relation to the mean of the two measurements of one observer on a subject. Lines are plotted 
indicating the limits of agreement using the formulas in our paper.













































LA= −0.21 mean biceps
this article. We plotted these LAs into the conventional Bland–Altman plot on the original 
scale. This back transformation yields diagonal lines representing the intraobserver limits of 
agreement (formulas given in Table 1).
Note that the LAs for the differences are proportional to the mean. For example, a mean 
biceps value of 10 mm has limits of agreement between the measurements of two observers 
of −2.10 and 2.10 mm, whereas if the mean biceps value increases to 20 mm, the LAs 
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Figure 4.  Bland and Altman plot on the original scale with back transformed limits of 
agreement. Interobserver variability is shown, with all observed pair wise differences between 
the measurements of biceps skinfold from two observers on the same subject. Lines are 
plotted indicating the limits of agreement using the formulas in our paper.
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LA= −0.85 mean biceps
Inter−observer plot
Figure 4 shows the calculated interobserver LAs on the original scale for the difference between 
the measurements of two observers as function of the mean of the measurements of a pair 
of two observers on one subject. To illustrate the agreement between the 13 observers in 
our data set, we considered all possible pairs of observers and for each pair we plotted the 
differences between the measurements of biceps skinfold per subject versus the mean of 
the measurements. Whether the difference between two observers was positive or negative 
was decided arbitrarily, because there is no clear ordering of the observers. We should be 



























Pairwise means of measurements of biceps skinfold from two 
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to 12 observer pairs. This explains the diagonal patterns of points in Figure 4 and results in 
downward trends for the smallest and largest mean values. Note that the downward trend 
for the observations with the largest mean values is caused by a small number of points and 
that the majority of the points is on the left side of the plot.
Conclusion
In conclusion, we have shown that correct and meaningful indicators of reproducibility can 
be estimated for log-transformed variables, which can be interpreted straightforwardly. As 
log transformations are frequently applied in reproducibility studies, it is important to use 
the correct formula in calculating a meaningful and interpretable CV and to provide easy 
interpretable Bland and Altman plots and LAs on the original scale to assess agreement.
Apart from log transformations by which a scale without an absolute minimum arises, 
there are additional approaches to approximate normality in which an absolute minimum 
is preserved. For example, a square root transformation could normalize right skewed data 
while the null value remains zero. However, in clinical practice, log transformations are much 
more frequently applied. An important advantage of a log transformation is that differences 
on the logarithmic scale can be transformed back to ratios on the original scale, as shown in 
the calculated limits of agreement.
In Bland–Altman plots, it is also possible to express the difference between measurements 
as a percentage of the average of the measurements, as shown in an example by Dewitte 
et al.9 However, with this approach the advantage of a direct overview of the exact value of 
both the measurement error and the corresponding limits of agreement in one plot is lost. 
In this situation, the absolute measurement error must be calculated from the mentioned 
percentages and means.
The approach of Bland and Altman plots for log-transformed data with back transformed 
limits of agreement, we provide here has almost never shown in literature on reproducibility 
of clinical measurements, apart from Dewitte et al. who briefly mentioned this method to be 
used in clinical chemistry.9 Though the Bland and Altman plots obtained by this method might 
appear somewhat unconventional at first glance, they provide an easy and reliable tool to see 
the LAs for different values of the variable at once on a clinical relevant scale.
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Intrauterine growth restriction: no unifying risk 









The validity and appropriateness of the metabolic syndrome as a cardiovascular risk factor 
is increasingly debated, partly due to the lack of a unifying underlying pathophysiological 
mechanism. Intra-uterine growth retardation (IUGR, low birth-weight by gender and 
gestational length) has been associated with several cardio-vascular problems and could be 
an important underlying risk factor for the metabolic syndrome. 
Methods
The association between IUGR (from the Norwegian Medical Birth Registry) and the metabolic 
syndrome in 7435 men and women aged 20-30 years from the population-based HUNT-2 
study was studied with logistic regression using fractional polynomial models. 
Results
In men, there were significant associations with several of the separate components of the 
metabolic syndrome: central obesity (exponential, P<0.001), raised triglycerides (negative 
linear, P=0.018), reduced HDL-cholesterol (U-shaped, P=0.086), raised blood pressure 
(negative linear, P=0.036), and impaired glucose-tolerance (negative linear, P=0.036). In 
women, there were significant associations with central obesity (positive linear, P<0.001) and 
raised blood pressure (negative linear, P=0.003) but not with the other components. When 
combining these components into the metabolic syndrome, an exponential association was 
found in men (P=0.017), i.e. increased risk in subjects with high birth weight only. In women, 
there was no association at all (P=0.959). 
Conclusions
Low birth weight was not associated with the metabolic syndrome at young adult age. 
Several associations between birth weight and the separate components of the syndrome 
were found, however, these associations were partly in different directions.  
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Introduction
The clustering of central obesity, impaired glucose tolerance or overt diabetes mellitus type 2, 
dyslipidemia, and hypertension is often referred to as the metabolic syndrome.1 The syndrome 
has a high prevalence worldwide, and it has been used widely in research and clinical practice 
as a cardiovascular risk factor.2 However, the validity and appropriateness of the metabolic 
syndrome concept is increasingly debated.3-6 Authorities have recently advised against it’s 
further use as much fundamental and clinical important information is missing.6 Making 
the diagnosis does not improve clinical utility or pathophysiological understanding: it is not 
clear that the syndrome confers a cardiovascular risk that is different from the sum of its 
components, nor is a unifying underlying mechanism established.7 
Intrauterine growth retardation (IUGR) leading to low birth weight has been suggested as 
an important risk factor for the development of the metabolic syndrome in analogy with 
associations established with adult cardiovascular disease.8 For that reason, even ‘the small 
baby syndrome’ was proposed as a new name for the metabolic syndrome.9 Later studies have 
often only studied separate components of the metabolic syndrome,10-12 and the findings of the 
few studies considering the entire metabolic syndrome itself are not unequivocal: associations 
with both low,13,14 and high birth weight15 were found in some studies, while other studies 
showed no statistically significant association at all.16-18 It is therefore unclear whether IUGR 
can be regarded as a common underlying risk factor for the metabolic syndrome. Most of 
these studies were relatively underpowered, and inappropriate statistical adjustment for 
current weight or BMI was applied in several studies.9,13,14,17,18
Hence, we studied the effect of birth weight on the metabolic syndrome and its individual 
components in young adults to avoid contamination of our study population with patients 
with frank diabetes or hypertension. The second Nord-Trondelag Health study (HUNT 2) is a 
large population based study with birth weights available from the Norwegian Medical Birth 
Registry. We studied IUGR as a possible unifying underlying risk factor for the metabolic 
syndrome in the light of an increasing skepticism of defining its individual cardiovascular 
components as a specific syndrome. 
Subjects and methods
Study population
The HUNT 2 study is a general health study conducted 1995-1997 in Nord-Trøndelag County, 
located in the middle of Norway with a population of 127,000 residents. All residents of this 
stable and homogeneous Caucasian population aged 20 years and older were invited for an 
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extensive questionnaire, a brief clinical examination, and a single venous blood specimen 
without specific instructions. Objectives, methods, and cohort retrieval of the HUNT 2 study 
are described in detail elsewhere.19 
At birth, each neonate in Norway is assigned a unique identification number for life. By using 
this identifier, individual linkage could be performed between the data collected in the HUNT 
2 study and perinatal data from the national Medical Birth Registry of Norway which exists 
since 1967. Therefore, all subjects aged 20-30 years living in Nord-Trøndelag county were 
eligible for the current study. Subjects with congenital malformations or women who were 
pregnant at the time of assessment were excluded because of possible influence on body 
composition and metabolism. 
Measurements
At birth, weight was measured in grams, and information on gestational age, congenital 
malformations, and pregnancy complications was registered by midwifes and obstetricians. 
Birth weight was expressed as a standard deviation score (SDS) to correct for gestational 
age and sex using Scandinavian reference values.20 Out-of-possible-range entries (gestational 
age <25 or >45 weeks, and/or birth weight <-5 SDS or >5 SDS) were considered as missing 
values.
In the HUNT 2 study information about diabetes and the use of antihypertensive drugs was 
obtained by questionnaire. Waist circumference was measured at the level of the umbilicus 
with a steel tape to the nearest 1.0 cm. Blood pressure was measured three times, and the 
means of the second and third measurement were taken. Time since last meal was recorded. 
Fresh serum samples were analyzed within three days. 
Definitions
The metabolic syndrome was defined according to the International Diabetes Federation 
(IDF) criteria: central obesity (waist circumference >94 cm (males) and >80 cm (females)) 
and at least two of the following four criteria: raised fasting triglyceride level (>1.7 mmol/l), 
reduced HDL cholesterol (<1.03 mmol/l (males) and <1.29 mmol/l (females)), raised blood 
pressure (systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg, 
and/or use of antihypertensive drug treatment), and raised fasting plasma glucose (≥ 5.6 
mmol/l or previously diagnosed diabetes mellitus type 2).21 We also used the American Heart 
Association / the revised US National Cholesterol Education Program Adult Treatment Panel 
(AHA / revised NCEP) criteria which differ from the IDF criteria only in defining an elevated 
waist circumference as ≥102 cm in Caucasian males and ≥88 cm in Caucasian females and at 
least any three out of the five criteria are required for the diagnosis.1
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Serum glucose and triglycerides require a fasting state, which was not requested in the large-
scale HUNT 2 study and therefore we adjusted them for time since the last meal. To that 
end, we used time specific percentiles for subjects with normal birth weight corresponding 
to the cutoff level used in the metabolic syndrome definition. For glucose we used the 95th 
percentile as this equals 5.6 mmol/l in the truly fasting group. For triglycerides we use the 
87.5th percentile as this equals 1.7 mmol/l. This is analogous to adjustments suggested by 
others.22,23 Glucose and triglyceride values did not need adjustment in 33% and 12% of 
subjects, respectively.
Statistical analysis 
Data were given by three categories of birth weight SDS using cut-off levels of -1.3 SDS 
and 1.3 SDS, compatible with the 10th and 90th sex and gestational age specific percentiles 
respectively. Birth weight < 10th percentile was considered Small for Gestational Age (SGA), 
birth weight between the 10th and 90th percentiles Appropriate for Gestational Age (AGA), and 
> 90th percentile Large for Gestational Age (LGA). The effect of birth weight SDS on the adult 
metabolic syndrome and its separate components was assessed by logistic regression analysis 
adjusting for the possible confounders age and being born after a pregnancy complicated by 
preeclampsia. To deal with non-linearity we used fractional polynomial functions in addition 
to the traditional approach of dividing continuous variables into categories.24 To check our 
adjustments for serum glucose and triglycerides in non-fasting subjects, we also performed 
subgroup analyses in those subjects who could be classified as either having the metabolic 
syndrome or not having the metabolic syndrome without being dependent on the adjusted 
serum glucose and / or triglyceride values. 
Results
In total, 8596 subjects, i.e. 48% of all subjects born 1967-1977 in Nord-Trøndelag county, 
participated in the HUNT 2 study. There were no significant differences in birth weight or other 
perinatal characteristics between our study population and the non-participating young adults 
of Nord-Trøndelag county (data not shown), 513 subjects had missing data for gestational 
age and /or birth weight, and 131 had impossible values for these parameters. 318 pregnant 
women were excluded. Of the remaining 7634 subjects 136 had missing data on one or more 
components of the metabolic syndrome, so that data of 7498 subjects (3554 males and 3944 
females) were analyzed. Birth weight ranged from 1020 to 5630 g, comprising 745 SGA, 
5967 AGA, and 745 LGA subjects. Mean birth weight in these groups was 2733 (326), 3506 
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Characteristics of our study population as young adults, i.e. data from the HUNT 2 examination, 
are displayed in Table 1. Unadjusted broad categories of birth weight showed that body 
size was positively associated with birth weight, while other demographic, medical history 
variables, and the components of the metabolic syndrome were either not different or could 
indicate a non-linear effect. There were no differences in time since last meal by birth weight 
group, and no associations with age, sex, waist circumference, HDL cholesterol or blood 
pressure. Serum glucose and triglycerides were significantly associated with time after meal 
(test-for-trend 0.006 and <0.001, respectively).
Table 2 shows the gender specific associations between birth weight SDS and the separate 
components of the metabolic syndrome, adjusted for age and preeclampsia as no other 
variables were significantly associated. In men, the odds ratio for central obesity seemed 
to be increased in subjects with very low birth weight SDS (OR 1.22) and in subjects with 
higher birth weight (OR 1.23, 1.45, and 2.06). Using fractional polynomial functions we 
found a highly significant over-all association with birth weight (P<0.001), but the functional 
form was a positive exponential function, i.e. no increased risk with lower birth weights. 
The expected negative linear effect, i.e. increased risk with lower birth weights, was found 
for raised triglycerides (P=0.018), raised blood pressure, (P=0.036) and impaired glucose 
tolerance (P=0.036). For reduced HDL-cholesterol there was a U-shaped association with birth 
weight (P=0.086). In women, there was a positive linear association between birth weight 
and central obesity, (P<0.001) and a negative linear association with raised blood pressure 
(P=0.003). Birth weight was not significantly associated with raised triglycerides, reduced 
HDL-cholesterol, or impaired glucose tolerance. 
The prevalence of the metabolic syndrome according to the IDF criteria was 9.7% in men 
and 7.2% in women. Table 3 shows a significant association between birth weight and the 
metabolic syndrome in men (P=0.017) with a positive exponential form, illustrated in Figure 1. 
This implies no increased risk among those with low birth weight SDS. Repeating the analyses 
in the subgroup of men not needing adjusted glucose and/or triglycerides cut-offs for the 
diagnosis of the metabolic syndrome gave very similar results. However, when metabolic 
syndrome was defined according to the AHA / revised NCEP criteria the association was 
weaker even in subjects with high birth weight. In women, there was no association between 
birth weight and the metabolic syndrome irrespective of syndrome definition and study group 




Figure 1. Absolute risk for developing the metabolic syndrome in (A) men and (B) women at age 20-30 years associated with birth weight SDS. The 
risk is expressed as a probability with 95% confidence intervals using logistic regression analyses with fractional polynomial functions adjusted for 
age and preeclampsia in the pregnancy. The reference lines indicate the observed prevalence in men and women. 
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Figure 1.  Absolute risk for developing the metabolic syndrome in (A) men and (B) women 
at age 20-30 years associated with birth weight SDS. The risk is expressed as a probability 
with 95% confidence intervals using logistic regression analyses with fractional polynomial 
functions adjusted for age and preeclampsia in the pregnancy. The reference lines indicate the 
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Discussion
This large-scaled population-based study describes the relationship between birth weight and 
the metabolic syndrome at young adult age. Birth weight SDS was both negatively, not at 
all, and positively associated with the separate components of the metabolic syndrome. In 
both men and women, low birth weight was not significantly associated with the metabolic 
syndrome itself. This does not support IUGR as a common pathophysiological mechanism for 
the metabolic syndrome. 
Our results might have been affected by limitations in study design or data collection. In 
the HUNT 2 study, subjects were not asked specifically to attend fasted. We therefore used 
different cut-offs for increased glucose and triglyceride depending on time after last meal, but 
some random misclassification can not be excluded. The effect of random misclassification is 
dilution of the observed effects, implying that we might have underestimated the true effect. 
However, repeating analyses in a smaller subgroup not relying on glucose or triglyceride 
values for diagnosing or excluding metabolic syndrome gave similar results. The participation 
rate in HUNT 2 for this age group was quite low (49%). However, there were no statistically 
significant differences in either birth weight or gestational age between participants and 
non-respondents. While non-response might have been related to the presence of metabolic 
syndrome, it is unlikely that this would result in bias, as bias requires selective non-response 
of a subgroup with both a certain birth weight category and a certain metabolic status. For 
example only a high non-response in those subjects with both a low birth weight and presence 
of the metabolic syndrome. This situation seems very unlikely. Another limitation is the absence 
of information about the possible confounders catch-up growth and breastfeading. Finally, in 
non-linear relationship settings, low number of data points in the very low or very high range 
pose a special problem which is difficult to assess. We therefore cannot totally exclude lack of 
power as a possible cause of non-significant associations in our study, but our study did after 
all include 750 SGA subjects.
The large study population in combination with few missing data on birth weight forms a major 
strength of our study. Furthermore, both birth weight and gestational age were registered 
at birth, which avoids recall bias. We expressed birth weight in SDS, which adjusts for the 
possible interference of sex and gestational age. Besides, information on potential important 
confounders was taken into account. Though studying the effect of early origins in relatively 
young adults has the clear advantage that disturbing life-style effects have accumulated 
less frequently, it might have been too young to detect some possible associations as the 
prevalence of the metabolic syndrome increases with increasing age. Therefore, the current 
research question should also be examined in an older population in future.
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Birth weight was inconsistently associated with the separate components of the metabolic 
syndrome in our study. The effect of high birth weight SDS on elevated waist circumference 
has also been described previously.13 A negative association was found between birth weight 
and triglycerides in men, and even though it has been found in earlier studies, it was not 
in the majority of (small) studies on this topic.25 However, most of these studies did not do 
separate analyses of men and women, and in those who did so a negative effect in men was 
found in five of six studies. We found a U-formed association between birth weight and HDL 
cholesterol in men. Most other studies have found no association,25 which could be caused by 
the use of linear regression analysis and the joint evaluation of men and women. Like other 
studies, we found only a small effect of low birth weight on elevated blood pressure.26,27 We 
found a negative association between low birth weight and glucose levels in males only, while 
a previous review found that most studies reported a negative association in both men and 
women.28 
Contrary to most previous findings, we did not find a significant association between low 
birth weight SDS and the metabolic syndrome. This discrepancy could partly be explained 
by publication bias, a phenomenon that has also been described for studies on fetal origins 
of blood pressure.27 Furthermore, a substantial part of the inverse associations found and 
published by others might also be explained by adjustments for current body size, mostly BMI. 
It is well known that BMI is positively related with risk factors for cardiovascular disease, and 
there is also a positive relation to birth weight.29 High BMI should therefore be considered as 
an intermediate rather than a confounder, and thus, we think it is theoretically unjustified to 
adjust for indicators of adult body composition.30,31 
A medical syndrome is usually defined as an aggregate of symptoms and signs conferring 
an increased risk unified by a common underlying pathophysiological process. The latter is 
important for a better understanding of the disease, both regarding prediction, diagnosis, and 
treatment. The metabolic syndrome was initially thought to be caused by insulin resistance, 
but more recent studies have shown that only 48% of insulin resistant subjects also have the 
metabolic syndrome.32 As current knowledge is based on association studies only, it may well 
be that there is a more basic defect resulting in insulin resistance and other cardiovascular 
risk factors. IUGR could be such a basic unifying defect, as low birth weight has nowadays 
repeatedly been associated with adult cardiovascular disease8 and its separate risk factors, 
both in this study as well as in other studies.13,26,27 The early studies supported low birth weight 
as a risk factor for the metabolic syndrome,9,13,14 but our data weigh against this hypothesis. 
Obviously, this does not exclude that a common pathological base for the metabolic syndrome 
might still be found in future, e.g. catch-up growth has been suggested to be such a risk 
factor.33 However, like with low birth weight and the metabolic syndrome, the majority of the 
current studies supporting this hypothesis studied one or more separate components of the 
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syndrome only.33 Furthermore, longitudinal data from population-based cohorts have recently 
shown that metabolic syndrome was only weakly associated with cardiovascular risk, and that 
the joint syndrome was not better than the sum of its components.34 In this context, finding 
opposite effects of low birth weight on different components of the metabolic syndrome but 
no effect on the syndrome itself does not provide additional support for metabolic syndrome 
concept.
In conclusion, several significant but inconsistent associations were found between birth 
weight and the separate components of the metabolic syndrome. However, no significant 
association was found between low birth weight and the metabolic syndrome itself. 
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Effect of intrauterine growth restriction 
on kidney function at young adult age: 












The hypothesis of intrauterine origin of adult disease is debated. We tested whether 




7,457 Norwegian adults aged 20 to 30 years participating in the population based Nord 
Trøndelag Health Study (1995-1997) with data for birth weight, gestational age, and maternal 
and perinatal risk factors registered at the Medical Birth Registry of Norway.
Predictor
Birth weight expressed as an SD score (SDS) to adjust for gestational age and sex. Subjects 
with a birth weight SDS less than -2.0, -2.0 to -1.3, and -1.3 to 1.3 were defined as very small, 
small, and appropriate for gestational age, corresponding to less than the 3rd, 3rd to 10th, 
and 10th to 90th percentiles, respectively.
Outcome and measurements
Kidney function estimated using the Cockcroft-Gault and isotope dilution mass spectrometry–
traceable 4-variable Modification of Diet in Renal Disease (MDRD) Study equation. Values less 
than the sex-specific 10th percentile were defined as low-normal kidney function.
Results
Compared with men with birth weight appropriate for gestational age (n = 2,755), odds 
ratios for low-normal creatinine clearance (<100 mL/min) were 1.66 (95% confidence interval 
[CI], 1.16 to 2.37) if small for gestational age (n = 261) and 2.40 (95% CI, 1.46 to 3.94) if 
very small for gestational age (n = 101). Kidney function estimated using the MDRD Study 
equation gave similar results. Women (n = 3,126, 283, and 112, respectively) had odds ratios 
of 1.65 (95% CI, 1.17 to 2.35) and 2.00 (95% CI, 1.21 to 3.29) for low-normal creatinine 
clearance (<80 mL/min), whereas the association was not significant using the MDRD Study 
equation. Using linear regression, creatinine clearance decreased by 4.0 mL/min (95% CI, 3.3 
to 4.6) in men and 2.9 mL/min (95% CI, 2.2 to 3.5) in women per 1-SDS decrease. Adjusting 
for possible confounders did not influence results. 
Limitations
Selection bias could be a problem because the participation rate was 49%, but there were 
no statistically significant differences between participants and nonparticipants regarding 
maternal and perinatal characteristics. Adjusting kidney function for body size can be a special 
problem in people with intrauterine growth restriction.
Conclusions
Although effects were still small in young adulthood, intrauterine growth restriction was 
significantly associated with low-normal kidney function. The effect was weaker and less 
consistent in women compared with men.
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Introduction
Intrauterine growth restriction (IUGR) is increasingly proposed as a mechanism in the 
pathogenesis of cardiovascular disease. An increased risk of hypertension,1 subclinical 
atherosclerosis assessed by using carotid intimamedia thickness measurement,2 nonfatal 
cardiovascular events3 and cardiovascular death4 were found in persons with low birth 
weight (BW). A few studies suggested that the propensity to chronic kidney disease may 
also be established in utero, and Brenner and Chertow5 were the first to postulate that IUGR 
may cause a decreased number of nephrons, leading to hypertension and reduced kidney 
function.
Low kidney volume and nephron number were observed after IUGR in several animal models 6,7 
and also in humans, newborns as well as adults, who died of nonrenal causes.8-10 The clinical 
consequences of these alterations were investigated at different levels, and associations 
were found of IUGR with microalbuminuria,11,12 faster progression of renal dysfunction in 
patients with specific kidney diseases,13,14 and end-stage renal disease (ESRD).15,16 Because 
IUGR also was associated with other diseases, such as type 2 diabetes mellitus, it is difficult 
to disentangle direct from indirect effects of IUGR on advanced renal failure. For that reason, 
follow-up studies of younger populations are necessary. A relationship between IUGR and 
renal function at 19 years of age was found in a prospective cohort study of subjects born 
very premature,17 however, to date, no cohort study investigated the effect of IUGR on young 
adult kidney function in a general population. 
We describe results from a large unselected cohort aged 20 to 30 years in which we assessed 
the relationship between BW (adjusted for sex and gestational age) and later kidney function 
to test the hypothesis that IUGR itself is primarily responsible for impaired kidney function. 
Because of the close relationship between kidney function and blood pressure, we also used 
blood pressure as a secondary outcome. 
Methods 
Population
The Health Survey of Nord Trøndelag (HUNT 2 Study) is a general health survey conducted in 
1995-1997 in Nord-Trøndelag County, Norway, with a population of 127,000. All residents of 
this stable and homogeneous population (97% whites) aged 20 years and older were invited 
for the survey. Objectives, methods, and participation in the HUNT 2 Study are described in 
detail elsewhere.18 The present study also used data from the national Medical Birth Registry. 
Since 1967, midwives or attending physicians have been obliged to forward medical data for 
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each childbirth to the Medical Birth Registry.19 Because all liveborns are assigned a unique 
identification number, linkage between databases is possible in Norway. The present study is 
based on an anonymized version of this record linkage and comprised a subgroup of the HUNT 2 
Study, i.e., subjects born between 1967 and 1977. All participants gave written informed 
consent, and the study was approved by the Regional Committee for Medical Research Ethics, 
the National Data Inspectorate, and the Directorate of Health and Social Affairs. Chronic 
kidney disease has a high prevalence in Norway, as well as in other western countries (10%).20 
ESRD incidence is low (99 cases/million inhabitants per year), and the most frequent causes 
are hypertension (29%), glomerulonephritis (18%), and diabetes (15%).21
Measurements
More than 99% of pregnant women in Norway receive standardized antenatal care.22 
Recording of live births is 100% complete in Norway. BW was recorded to the nearest 10 g, and 
gestational age was based on the last menstrual period. Data for congenital malformations, 
pregnancy complications, and maternal conditions were also recorded. Diagnostic criteria for 
preeclampsia fulfilled the 1972 recommendations of the American College of Obstetricians 
and Gynecologists, which defined preeclampsia as increased blood pressure (≥140/90 mm 
Hg) after 20 weeks of gestation together with proteinuria, edema, or both. 
Relevant data at a young adult age were obtained as part of the HUNT 2 Study: medical 
history, risk factors, education, and family history of cardiovascular disease. Height was 
measured to the nearest 1.0 cm, and weight, to the nearest 0.5 kg, with participants lightly 
clothed without wearing shoes. Blood pressure was measured by specially trained nurses or 
technicians using a Dinamap 845 XT (Critikon, Tampa, FL) based on oscillometry. Cuff size was 
adjusted after measuring arm circumference. Blood pressure measurements were performed 
after the participant had been seated for at least 2 minutes with the cuff around the arm 
with the arm resting on a table. Blood pressure was measured automatically 3 times at 
1-minute intervals. For all analyses, mean values of the second and third systolic and diastolic 
measurements were obtained. Fresh serum samples were analyzed within 2 days on a Hitachi 
911 Autoanalyzer (Hitachi, Mito, Japan), applying reagents from Roche (Roche Diagnostics, 
Mannheim, Germany). Serum creatinine was measured by using a blank-rate Jaffé method.
Statistical Analysis
Subjects with congenital malformations and women pregnant at the time of assessment 
were not eligible for inclusion because of possible influences on body composition and renal 
function. There is controversy about how to index kidney function for body size.23 Therefore, 
we used different estimates of kidney function. Creatinine clearance was estimated using 
the Cockcroft-Gault formula, and glomerular filtration rate (GFR) was estimated using the 
isotope dilution mass spectrometry (IDMS)-traceable 4-variable Modification of Diet in Renal 
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Disease (MDRD) Study equation. Results are presented as not adjusted for body surface area 
(in milliliters per minute) and adjusted for body surface area (in milliliters per minute per 1.73 
m2) for both equations.24,25
Creatinine clearance (mL ⁄ min) 
= (140 - age) / (serum creatine[mg ⁄ dL]) x (weight[kg] / 72(x 0.85 if female) 
GFR (mL/min / 1.73m2) 
= 175 x serum creatinine (mg/dL) - 1.154 x age - 0.203 (x 0.742 if female) 
For the MDRD Study equation, now designed for use with IDMS-traceable serum creatinine 
values to avoid problems with interlaboratory calibration differences, we recalibrated our 
original Jaffè-based creatinine values to the Roche enzymatic method.26
To reflect intrauterine growth, we expressed BW as an SD score (BW-SDS) to correct for 
gestational age and sex by using Scandinavian references.27 Very small for gestational age 
(VSGA) was defined as a BW less than the 3rd percentile for gestational age (< -2.0 SDS); 
small for gestational age (SGA), as a birth weight between the 3rd and 10th percentile (-2.0 
to -1.3 SDS); and appropriate for gestational age (AGA), as a birth weight between the 10th 
and 90th percentile (-1.3 to 1.3 SDS). Similar categories were used for BW (2,450, 2,870, and 
4,190 g, respectively) and gestational age (36, 38, and 42 weeks, respectively). We used low-
normal kidney function, defined as values less than the sex-specific 10th percentile, as our 
primary outcome. Blood pressure was a secondary outcome. 
Based on the Medical Birth Registry, we compared obstetric and neonatal characteristics of 
HUNT 2 participants and nonparticipants by using 2-sample t-test or Mann-Whitney U test, 
when appropriate. Nonlinear associations in our study population were then tested for by 
categorizing BWSDS, BW, and gestational age, and age-adjusted logistic regression analysis 
was used to assess the effect of IUGR. Linear regression was used if appropriate to assess the 
effect of IUGR as a continuous variable. Blood pressure was analyzed as a continuous variable. 
All analyses were performed separately for men and women,23 and analyses were repeated 
with adjustment for maternal risk factors (age, preexisting diabetes and/or kidney disease, 
and preeclampsia), adult smoking, and educational level.
Results
Forty-nine percent of all adults in Nord-Trøndelag County born between 1967 and 1977 
participated in the HUNT 2 Study (n = 8,666). BW-SDS was missing for 490 participants, and 
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133 participants had improbable values BW-SDS < -5 or > 5), leaving 8,043 subjects eligible. 
As listed in Table 1, based on the Medical Birth Registry, there were no significant differences 
in BWs or other obstetric, neonatal, and maternal characteristics between study subjects and 
nonparticipants in Nord-Trøndelag County. The proportion of males was significantly lower 
among participants. Persons with congenital malformations (n = 126) and women pregnant at 
the time of the study (n = 323) were excluded, and 137 had missing data for serum creatinine 
or weight needed for estimating kidney function. Therefore, data from 7,457 subjects (3,534 
males and 3,923 females) were analyzed. BWs ranged from 1,020 to 5,630 g, comprising 
213 VSGA subjects, 544 SGAsubjects, 5,881 AGAsubjects, and 819 large-for-gestational-age 
subjects. Mean BWs in these groups were 2,448 ± 311 (SD), 2,851 ± 253, 3,499 ± 411, and 
4,321 ± 391 g, respectively. Table 2 lists characteristics of the study groups at the time of the 
HUNT 2 examination. 
Table 1.  Demographic, obstetric, and neonatal characteristics of all subjects born 1967-1977 
in Nord-Trøndelag county, Norway





Men (%) 45.4 59.0 <0.001
Dead after HUNT 2 (%) 0.5 0.7 0.04
Maternal hypertension (%) 0.1 0.1 0.9
Maternal chronic kidney disease (%) 0.7 0.8 0.4
Maternal diabetes mellitus (%) 0.1 0.1 0.9
Pregnancy-induced hypertension (%) 1.3 1.2 0.9
Preeclampsia (%) 4.6 4.5 0.8
Obstetric complications (%) 21.9 23.0 0.09
Gestational age (wk) 39.9 ± 1.8 39.9 ± 1.9 0.9
BW (g) 3,510 ± 539 3,515 ± 535 0.5
BW < 2,500 g (%) 3.4 3.4 0.9
BW > 4,000 g (%) 16.2 16.4 0.8
BW-SDS 0.02 ± 1.08 −0.01 ± 1.08 0.2
BW-SDS −2.0 to −1.3 (SGA) (%) 7.2 7.5 0.4
BW-SDS <−2.0 (VSGA) (%) 2.9 3.3 0.1
Note: Values expressed as mean ± SD or percent. Binary variables compared by using chi-square test, 
continuous variables compared by using 2-sample t-test. Subjects born SGA and VSGA were defined by 
using BW-SDSs to also account for gestational age and sex.
Abbreviations: HUNT 2, Nord Trøndelag Health Study; BW, birth weight; SDS, SD score; SGA, small for 
gestational age; VSGA, very small for gestational age.
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Table 2.  Characteristics of HUNT 2 participants examined 1995-1997 by category of 
intrauterine growth
VSGA (n = 213) SGA (n = 544) AGA (n = 5881) P
Age (y) 24.4 ± 2.8 24.7 ± 2.9 24.7 ± 2.9 0.1
Men (%) 47.4 48.0 46.8 0.7
Low education* (%) 48.3 47.7 44.4 0.08
Height (cm) 169.4 ± 9.2 170.2 ± 8.5 173.0 ± 8.9 <0.001
Weight (kg) 70.0 ± 13.9 71.4 ± 13.5 74.2 ± 14.1 <0.001
Body surface area (m2) 1.80 ± 0.20 1.82 ± 0.19 1.87 ± 0.20 <0.001
Body mass index (kg/m2) 24.3 ± 4.0 24.6 ± 4.0 24.7 ± 3.9 0.3
Family history of DM or CVD (%) 33.8 27.0 27.6 0.2
Physical inactivity† (%) 13.5 13.1 13.6 0.8
Current smoking (%) 35.2 29.4 28.0 0.04
Diabetes (%) 0.9 0.9 0.5 0.2
Antihypertensive treatment (%) 0.0 0.2 0.4 0.3
Systolic blood pressure (mm Hg) 128.7 ± 12.7 127.4 ± 13.8 126.2 ± 13.1 <0.01
Diastolic blood pressure (mm Hg) 73.1 ± 9.0 71.7 ± 8.6 71.2 ± 8.6 <0.01
Note: Variables presented as mean ± SD or percentage. VSGA birth weight adjusted for gestational age 
and sex less than 3rd percentile, SGA birth weight adjusted for gestational age and sex between 3rd and 
10th percentiles, and AGA birth weight adjusted for gestational age and sex between 10th and 90th 
percentiles. Binary variables compared by using the linear-by-linear test for trend in a 2 × 3 cross-table; 
continuous variables compared using 1-way analysis of variance.
Abbreviations: HUNT 2, Nord Trøndelag Health Study; SGA, small for gestational age; VSGA, very small 
for gestational age; AGA, appropriate for gestational age; DM, diabetes mellitus; CVD, cardiovascular 
disease (i.e. cerebral stroke or myocardial infarction age < 60 years).
* Less than 12 years. 
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Table 3 lists risks for low-normal kidney function, defined as estimates less than the 10th 
percentile, for different categories of BW, gestational age, and BW by gestational age. In 
men, crude BW less than the 3rd percentile (< 2,450 g) was associated with at least a 2 
times greater risk of low-normal kidney function independent of how kidney function was 
estimated. Similar results were found for those born with a gestational age less than 36 
weeks. When assessing intrauterine growth as BW adjusted for gestational age, we found 
that those born SGA (3rd to 10th percentile) also had significantly increased risk. Defining 
low-normal kidney function as Cockcroft-Gault estimates less than 100 mL/min (< 1.67 mL/s), 
men born VSGA (< 3rd percentile) had an odds ratio (OR) of 2.40 (95% confidence interval 
[CI], 1.46 to 3.94) compared with those born appropriate for gestational age. Men born SGA 
(3rd to 10th percentile) had an OR of 1.66 (95% CI, 1.16 to 2.37) for low-normal kidney 
function. A significant trend for increasing risk with decreasing BW-SDS scores was found (P < 
0.001). In women, the association with IUGR was much less consistent and highly dependent 
on how kidney function was estimated. Defining low-normal kidney function as Cockcroft-
Gault estimates less than 80 mL/min (< 1.33 mL/s), a significant association was found with 
BW adjusted for gestational age for women born VSGA (OR, 2.00; 95% CI, 1.21 to 3.29) 
and SGA (OR, 1.54; 95% CI, 1.08 to 2.19), and there was also a significant test for trend (P 
< 0.001). However, there was no significant association with BW or gestational age. When 
using other estimates for kidney function, no significant association was found. 
Table 4 lists the effect of IUGR on kidney function as a continuous variable by using linear 
regression analysis. In men, there was a significant association between BW and all kidney 
function estimates. When BW increased by 1 kg, creatinine clearance increased by 7.3 mL/
min (0.12 mL/s; 95% CI, 6.0 to 8.6). However, there was no association with gestational 
age, and the association with BW adjusted for gestational age was weaker than with crude 
BW. Creatinine clearance increased by 4.0 mL/min (0.07 mL/s; 95% CI, 3.3 to 4.6) per 1-SDS 
increase in BW. Adjustment for potential confounders, such as maternal risk factors (age, 
diabetes, kidney disease, and a preeclamptic pregnancy), adult smoking, and educational 
level did not change the strength of the observed associations. In women, there was also a 
significant, but less strong, association between BW and kidney function. When BW increased 
by 1 kg, creatinine clearance increased by 5.5 mL/min (0.09 mL/s; 95% CI, 4.2 to 6.8). There 
was no association with gestational age, and the association with BW adjusted for gestational 
age was weaker: creatinine clearance increased by 2.9 mL/min (0.05 mL/s; 95% CI, 2.2 to 
3.5) per 1-SDS increase in BW. There was no significant association when estimating kidney 
function using the MDRD Study equation (in milliliters per minute per 1.73 m2). Results of 
multiadjusted analyses were very similar to those of age-adjusted analyses. 
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mm Hg (95% CI, 0.02 to 1.45) for each 1-kg increase in BW in men and by 1.27 mm Hg 
(95% CI, 0.59 to 1.96) in women after adjustment for age at the HUNT 2 examination. The 
decrease was 0.38 mm Hg (95% CI, 0.01 to 0.75) for each 1-SDS increment in BW adjusted 
for gestational age in men and 0.57 mm Hg (95% CI, 0.24 to 0.91) in women. Diastolic blood 
pressure did not decrease significantly in men, but in women, it decreased 0.68 mm Hg (95% 
CI, 0.17 to 1.18) for each 1-kg increase and 0.42 mm Hg (95% CI, 0.17 to 0.66) for each 
1-SDS increment in BW. Exclusion of subjects administered antihypertensive medication did 
not change results. Adjustment for maternal risk factors (age, diabetes, kidney disease, and 
preeclampsia), current smoking, and education at adult age resulted in only minor changes 
in the observed associations, whereas adjustment for adult weight increased the coefficients 
significantly.
Discussion
In this population-based study, we found that subjects born after IUGR had an increased risk 
of low-normal kidney function at a young adult age. When adjusting BW for gestational age, 
creatinine clearance decreased by 4.0 mL/min (0.07 mL/s) in men and 2.9 mL/min (0.05 mL/s) 
in women per 1-SDS decrease. If intrauterine growth was expressed as crude BW, creatinine 
clearance decreased by 7.3 mL/min (0.12 mL/s) in men and 5.4 mL/min (0.09 mL/s) in women 
per 1-kg decrease in BW. 
Several method issues need discussion. Kidney function was not measured directly, and 
although the methods used for estimating kidney function previously were found to be 
unbiased in the present study group,26 their accuracy is only moderate and misclassification 
can occur. Urine albumin is another important marker of kidney damage, but this was 
available for only a subgroup of participants and could not be used in our analyses. An 
optimal diagnosis of IUGR requires repetitive measurements of fetal growth parameters by 
using ultrasound. However, in epidemiological studies of larger numbers of pregnancies, such 
as ours, this procedure was not feasible; therefore, the concept of SGA was used as a proxy 
of IUGR. Because this reflects only the situation at birth, there will be some misclassification 
because not all SGAs result from IUGR and some non-SGAs experienced IUGR.
It is well documented that subjects with IUGR have lower adult height, lower muscle mass, and 
higher fat content.28,29 Because of this body composition, they might have serum creatinine 
values that are underestimated and weights that are overestimated relative to height. Because 
the Cockcroft-Gault formula is based on the product of these 2 variables, it is conceivable 
that they balance each other and therefore give a reliable estimate of kidney function. 
































































































































































































































































































































































































































































































































































































































































































































































































might overestimate kidney function in subjects with IUGR, and a possible low-normal kidney 
function will be veiled, rendering the observed ORs conservative. Formulas including lean 
body mass could have been well suited for this research question,30 but information for lean 
body mass was not available. 
Furthermore, instead of expressing kidney function traditionally per surface area, some 
recommend to adjust for body size in the regression analysis.31-33 This is controversial in 
“fetalorigin” studies because such body size variables as extracellular volume, body surface 
area, and body mass index are influenced by central obesity, which must be considered as 
an intermediate variable in the causal pathway between IUGR and later kidney function. 
Adjustment for height is suggested because smaller body size might require less absolute kidney 
filtration, but the use of noncorrected kidney function estimates is recommended until these 
problems are clarified further.23 We therefore used Cockcroft-Gault estimates (milliliters per 
minute) as our primary outcome, but also used other estimates of kidney function. Especially 
in men, all outcome variables were consistently associated with BWSDS, indicating that the 
relation between BW and kidney function probably is not caused by chance finding or bias. 
However, in women, associations were less strong. Nonresponse may lead to selection bias. 
However, participants and nonparticipants did not differ in perinatal characteristics, thereby 
making an effect of selection bias less likely. Estimating gestational age based on date of last 
menstrual period is prone to error, but sonographic estimates were not routinely performed 
in Norway in the 1970s. A major strength of our study is the prospective design. Furthermore, 
the completeness of the perinatal registration enabled us to adjust BW for gestational age, 
which is considered important to obtain a valid measure of a subjects’s exposure to IUGR.7,34-36 
We found that IUGR was associated with low-normal kidney function in young adults from the 
general population. This is consistent with findings in subjects born very prematurely17. A low 
nephron number was observed in low-BW subjects at autopsy. This could explain associations of 
low BW with such clinical outcomes as albuminuria, low-normal kidney function, and ESRD.6-17,37 
However, these are only a few studies, sometimes with a weak design, and the effects found 
were not strong. Case-control studies showed an OR of 1.5 for ESRD in subjects with BWs less 
than 2,500 g, but data for BW were missing in half the cases.15,37
Blood pressure was used as a secondary outcome because of the central role of the kidneys 
in blood pressure regulation, and IUGR is also postulated to lead to hypertension and reduced 
kidney function through a decreased number of nephrons.5 We found that systolic blood 
pressure increased by 0.7 to 1.3 mm Hg per 1-kg decrease in BW. This is in accordance 
with 2 large meta-analyses that found systolic blood pressure increased by 1 to 2 mm Hg 
per 1-kg decrease in BW38,39 and strengthens the external validity of our results. Earlier 
studies reported much larger associations, eg, an increase in systolic blood pressure of 11 
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mm Hg per 1-kg lower BW in middle-aged subjects.1 These early more radical conclusions 
most likely reflect random error, publication bias, and inappropriate adjustment for current 
weight.38 Theoretically, if there was no correlation between BW and adult blood pressure, but 
both positively correlated with adult body size, adjusting for adult body size could induce a 
negative correlation between BW and blood pressure.40 Our study shows that such adjustment 
clearly increased the magnitude of the association, but did not create it. Others also found 
similar results,39 and noting that low BW is associated with low adult weight, which in turn is 
associated with lower blood pressure, it is not yet clear how to solve this problem. 
Sex was reported to modulate the effect of IUGR in many experimental animal models.41-43 
In different species and using different methods for creating an adverse fetal environment, 
male offspring consistently experienced worse outcomes. Our findings are in accordance with 
these results. The analysis of discrete outcomes showed nearly no association between IUGR 
and low normal kidney function in women, but analysis of continuous outcomes showed 
a general effect, although weaker, in women as well, which can be related to the greater 
power present with continuous data. Consequently, the intrauterine origin of adult disease 
hypothesis may be of greater importance in men than women. Still, bias caused by kidney 
function estimation methods veiling an effect also in females cannot be ruled out; the effect 
of IUGR on blood pressure was present in both men and women. 
The impact of low BW on public health in developed countries has been questioned.44 The 
question remains whether IUGR causes adult disease or IUGR is caused by a factor that also 
causes adult disease, either of genetic or permanent environmental nature. In the latter case, 
IUGR predicts rather than causes adult disease. Irrespective of mechanisms, our findings, even 
if effects are small, may have important implications. Small effects found at a young adult 
age may progress to larger effects at older ages because the kidney and vasculature no longer 
may be able to compensate with hyperfiltration, vasodilatation, and antioxidant pathways. 
Such amplification throughout life was clearly shown for blood pressure.39,45 
Moreover, the potential effect of intervention can be different in developing countries. Mean 
BW is nearly 1 kg less in South Asia compared with western Europe.46 Modifiable factors, such 
as shortage of food, micronutrient deficiencies, sex discrimination, and intentionally decreased 
food intake during pregnancy because of cultural beliefs may be of greater importance for 
BW than racial differences per se.35,47,48 Although most fetal origins of adult disease studies 
were conducted in white populations, an increasing number of studies from China and 
India confirm the influence of low BW on adult blood pressure, glucose metabolism, and 
other cardiovascular risk factors.49-52 Mortality and morbidity from coronary artery disease, 
diabetes mellitus, and chronic kidney disease are expected to increase by 200% to 400% in 
developing countries during the next 30 years because of increased longevity and adverse 
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lifestyle changes.53,54 These estimates, which are based on changes in demographic and 
lifestyle factors alone, could even be too conservative because a large proportion of these 
populations were exposed to IUGR.
In conclusion, we found that IUGR was associated with low-normal kidney function in this 
large Norwegian population-based cohort study. The association was stronger in men than 
women and persisted after adjusting for potential important perinatal confounders. Although 
the absolute effects found were small, our results may have important etiologic implications.
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Increasing evidence indicates that adult body composition is associated with prenatal and 
infancy weight gain, but the relative importance of different time periods has not been 
elucidated. 
Objective
The objective was to study the association between prenatal, early postnatal, and late infancy 
weight gain and body mass index (BMI), fat mass, and fat distribution in young adulthood. 
Design
We included 403 men and women aged 19 y from a Dutch national prospective follow-up 
study who were born at <32 wk of gestation. BMI, waist circumference, and waist-to-hip 
ratio SD scores and subscapular-to-triceps ratio, percentage body fat, fat mass, and fat-free 
mass at age 19 y were studied in relation to birth weight SD scores, weight gain from preterm 
birth until 3 mo postterm (early postnatal weight gain), and weight gain from 3 mo until 1 y 
postterm (late infancy weight gain). 
Results
Birth weight SD scores were positively associated with weight, height, BMI SD scores, and 
fat-free mass at age 19 y but not with fat mass, percentage body fat, or fat distribution. Early 
postnatal and late infancy weight gain were positively associated with adult height, weight, 
BMI, waist circumference SD scores, fat mass, fat-free mass, and percentage body fat but not 
with waist-to-hip ratio SD scores or subscapular-to-triceps ratio. 
Conclusions
In infants born very preterm, weight gain before 32 wk of gestation is positively associated 
with adult body size but not with body composition and fat distribution. More early postnatal 
and, to a lesser extent, late infancy weight gain are associated with higher BMI SD scores and 
percentage body fat and more abdominal fat at age 19 y. 
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Introduction
Obesity is a major health problem throughout the world. Numerous studies have shown an 
association between obesity and various cardiovascular disease risk factors, such as diabetes, 
hypertension, and dyslipidemia.1-3 Obesity is also associated with an increased risk of death.4 
Fetal life and the early postnatal period have been suggested to be important for the 
development of adult obesity.5,6 The Dutch famine studies have shown that reduced maternal 
calorie intake during the first 2 trimesters of pregnancy might increase the risk of adult obesity.7,8 
The association between birth weight, mainly an indicator of fetal growth during the third 
trimester, and adult obesity is equivocal.9 In several studies, a linear positive association was 
found,10-12 whereas in others a J- or U-shape association13,14 or no association15 was observed. 
In these studies, obesity was expressed as body mass index (BMI; in kg/m2), which includes 
both fat mass and fat-free mass. 
In studies about fat mass and fat distribution, low birth weight has been associated with a 
more central pattern of fat distribution16,17 and a lower BMI, mostly because of a lower lean 
body mass and not a lower fat mass18-22. In addition, a rapid rate of weight gain during early 
infancy has been associated with both a higher BMI23 and more fatness and a more central 
pattern of fat distribution in childhood.6 In certain specific populations, early growth has 
been positively associated with obesity and lean body mass in adulthood.24,25 However, the 
associations between birth weight and adult body composition have not been consistently 
found in all populations,26,27 and in various studies the associations became significant only 
after adjustment for adult BMI.16,17,21,22 It is still unclear whether the associations found 
between early postnatal weight gain and fat mass and fat distribution in childhood persist 
into adulthood, and even less is known about fetal growth during the first 2 trimesters of 
pregnancy and subsequent adult body composition in humans. 
We studied the relation between birth weight and early postnatal weight gain and adult 
BMI, fat mass, and fat distribution within the scope of the Project On Preterm and Small-
for-gestational-age infants (POPS), a national cohort of individuals born very preterm. In this 
prospective study, birth weight could be used as an indicator of fetal growth during the first 
2 trimesters, whereas growth during the third trimester and the period thereafter could be 
monitored well ex utero. We studied the relative predictive value of weight gain before 32 wk 
of gestation, during the period from preterm birth until 3 mo postterm (early postnatal weight 
gain), and from 3 mo until 1 y postterm (late infancy weight gain) for BMI, fat distribution, 





The subjects were participants of the POPS study. The POPS cohort comprises 94% of all 
live born infants in the Netherlands between 1 January and 31 December 1983 after a 
gestation of <32 completed weeks, with a birth weight of <1500 g, or both28. The physical 
and psychosocial outcomes of the POPS cohort have been intensely studied over the years.28,29 
In the current study, conducted when the subjects were 19 y of age, only those subjects 
with a gestational age <32 wk were studied. Subjects with congenital malformations leading 
to changes in body proportions and body composition (eg, focomely, amely, chromosomal 
abnormalities, and inborn errors of metabolism) were not eligible for inclusion. The study was 
approved by the medical ethics committee of all participating centers, and written informed 
consent was obtained from all participants. 
Measurements
Weight (g), length (cm), and head circumference (cm) were measured at birth and expressed 
as SD scores to correct for gestational age and sex with the use of Swedish references for very 
preterm infants.30 At the ages of 3 mo and 1 y postterm, weight and length were measured 
at the outpatient clinics of the participating centers by trained physicians and nurses. These 
measurements were expressed as SD scores with the use of Dutch reference values.31 Weight 
gain between birth and the age of 3 mo postterm (early postnatal weight gain) and between 
the ages of 3 mo and 1 y postterm (late infancy weight gain) were computed as ∆-SD 
scores. 
Anthropometric measurements were performed in 10 centers in the Netherlands by 15 nurses 
and physicians according to standardized procedures when the subjects had reached the age 
of 19 y. All assessors had received extensive training before the start of the study; during 
the study, retraining and standardization were carried out at 2-mo intervals to maximize 
interobserver reliability. The assessors were blinded with respect to the birth weight or duration 
of gestation of the subjects. 
Subjects were measured barefoot while wearing underclothing. Weight was measured on a 
balance scale to the nearest 0.1 kg. Height was measured to the nearest 0.1 cm with a fixed 
stadiometer. BMI was calculated as weight in kg/height squared in cm.2 Waist circumference 
was measured at the level of the umbilicus after full expiration and hip circumference at 
the level of the greater trochanter, both with the use of a flexible tape measuring to 0.1 
cm accuracy. The waist-to-hip ratio was calculated. Four skinfold-thickness measurements 
were taken in duplicate with a calibrated skinfold caliper on the left side of the body at the 
triceps, biceps, subscapular, and iliacal regions according to guidelines of the World Health 
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Organization (biceps and subscapular)32 and Falkner and Tanner (triceps and iliacal).33 The sum 
of the 4 skinfold thicknesses was used as a measurement of overall subcutaneous fatness. 
The ratio of subscapular-to-triceps-skinfold thickness was calculated as an index of truncal to 
peripheral adiposity.34 Fat mass and the corresponding fat-free mass were computed by using 
the equations of Durnin and Rahaman.35 All outcome measures at age 19 y, except for the 
derived outcomes, were expressed as SD scores according to recent Dutch references.31,36,37 
Multivariate linear regression analyses were performed with SPSS 11.0 software (SPSS Inc, 
Chicago) to assess associations between prenatal, early postnatal, and late infancy weight 
gain and the outcome measures at age 19 y. To disentangle the effects of birth weight, 
early postnatal weight gain, and late infancy weight gain on adult outcomes, early postnatal 
weight gain was corrected for birth weight, and late infancy weight gain was corrected for 
both the effect of birth weight and the effect of early postnatal weight gain. This correction 
was performed by entering the variables mentioned above into multivariate regression 
models. An interaction term, computed as the product of birth weight (SD scores) and early 
postnatal weight gain (∆-SD scores) and late infancy weight gain (∆-SD scores), respectively, 
was introduced to assess whether the effect of early postnatal and late infancy weight gain 
on outcome measures at age 19 y was different for those individuals with low birth weights 
compared with those with higher birth weights. The relative importance of weight gain 
during the various time periods was studied by comparing the changes in explained variance 
(R2) for each period. 
Because it was not possible to use an SD score for variables derived from skinfold thicknesses, 
regression analyses with these outcome measures were corrected for sex. The analyses with 
waist and hip circumferences, fat mass, and fat-free mass at age 19 y as outcomes were 
also adjusted for variations in adult body size by adjusting for current height (SD scores). 
The analyses with height (SD scores) at age 19 y as the outcome measure were adjusted for 
target height (SD scores) computed as (midparental height ± 6.5 cm) + 4.5 cm (estimated 
secular trend per generation). All analyses were repeated with adjustment for the possible 
confounders race (white versus nonwhite), socioeconomic status (measured on a 6-point 
scale in which 1 was lowest and 6 was highest), and physical activity (measured on a 3-point 
scale). 
Results
In 1983, 1012 infants who were born before 32 wk of gestation were included in the POPS 
cohort; 669 without congenital malformations were still alive at age 19 y. Of these subjects, 
415 (194 males and 221 females) gave informed consent for the present study (response rate 
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62%). No anthropometric measurements were performed in 8 subjects either because these 
subjects were wheelchair bound or because no calibrated instruments were available. Four 
subjects were excluded from the analyses because of medical conditions or because they were 
taking medication that could lead to aberrations in body proportions and body composition: 
2 subjects used oral corticosteroids, 1 woman had anorexia nervosa, and 1 woman was 
pregnant at the time of the study. The study population thus included 403 subjects in whom 
anthropometric measurements were performed at age 19 y (Figure 1). 
Characteristics of the subjects are given in Table 1. Nonresponse was higher among males, 
nonwhites, and those with a mother with a low educational level. Mean birth weight (SD scores) 
and gestational age did not differ significantly between responders and nonresponders. 
Figure 1.  Flow chart of the study sample
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The anthropometric characteristics of the response group are provided in Table 2 as absolute 
values and SD scores. For both males and females, the mean values for height, weight, and 
BMI were lower than the means of the Dutch reference population of 19-y-olds, whereas 
the mean values for waist circumference, waist-to-hip ratio, and the sum of the skinfold 
thicknesses were greater than the Dutch population means. 
Table 1.  Birth and neonatal characteristics of infants born very preterm 
Characteristic Responders (n = 403)1 Nonresponders (n = 254)1
Demographic
    Sex (% male) 46.4 65.72
    Race (% white) 87.7 80.23
    Low-educational-level mother (%) 38.9 56.52
Obstetric
    Multiple birth (%) 22.8 21.7
    Hypertension during pregnancy (%) 17.6 15.7
    Diabetes mellitus gravidarum (%) 5.0 4.3
    Smoking during pregnancy (%) 28.0 29.5
    Drugs and alcohol intoxication (%)4 52.0 52.0
    Elective delivery (%) 19.4 13.43
Birth
    Gestational age (wk) 29.7 ± 1.55 (25.7–31.9)6 29.8 ± 1.5 (25.4–31.9)
    Birth weight (g) 1316 ± 336 (560–2580) 1347 ± 274 (610–2000)
        (SD score) –0.13 ± 1.0 (–2.98–2.70) –0.091 ± 0.88 (–3.60–1.66)
    Birth length (cm)
        (cm) 39.1 ± 3.4 39.6 ± 2.93
        (SD score) –0.12 ± 1.2 –0.062 ± 1.13
    Head circumference at birth
        (cm) 27.4 ± 2.1 27.6 ± 1.9
        (SD score) 0.029 ± 1.2 –0.091 ± 1.0
Postnatal
    Weight at 3 mo
        (kg) 5.1 ± 0.90 5.3 ± 0.88
        (SD score) –0.94 ± 1.3 –0.90 ± 1.4
    Weight at 1 y
        (kg) 8.9 ± 1.2 9.1 ± 1.4
        (SD score) –0.98 ± 1.2 –0.94 ± 1.4
1 The sample size was slightly less for some variables. 
2,3 Significantly different from responders (chi-square test for dichotomous variables and two-sample t 
tests for continuous variables): 2 ; P < 0.001, 3 ; P < 0.05. 
4  Smoking, drinking alcohol, or using soft drugs, hard drugs, or methadone during pregnancy. 
5  x± SD (all such values). 
6  Range (all such values). 
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Prenatal, early postnatal, and late infancy weight gain and adult anthropometry
The associations between prenatal, early postnatal, and late infancy weight gain and the 
anthropometric outcomes at age 19 y are shown in Table 3. Birth weight (SD scores) was 
positively associated with adult height, weight, BMI, and waist circumference (SD scores), 
although the 95% CIs for the latter 2 variables almost included zero. There was also a positive 
association between birth weight (SD scores) and both fat mass and fat-free mass but not 
between birth weight (SD scores) and percentage body fat at age 19 y. When adjusted 
for current height (SD scores), the association between birth weight (SD scores) and waist 
circumference disappeared. The regression coefficient of the association between birth 
weight (SD scores) and fat-free mass decreased, and the association between birth weight 
(SD scores) and fat mass became nonsignificant after correction for current height (SD scores). 
No significant associations were found between birth weight (SD scores) and the waist-to-hip 
ratio (SD scores), the sum of skinfold thicknesses (SD scores), and the subscapular-to-triceps 
ratio at age 19 y. 
Table 2.  Characteristics of the response group at age 19 year by sex 
Males (n = 187)a Females (n = 216)a P b
Height
    (cm) 179.4 ± 7.9c 166.4 ± 7.1 0.001
    (SD score) –0.55 ± 1.1 –0.60 ± 1.1 0.633
Weight
    (kg) 69.9 ± 12.1 60.5 ± 10.6 0.001
    (SD score) –0.41 ± 1.2 –0.48 ± 1.4 0.583
BMI
    (kg/m2) 21.7 ± 3.1 21.8 ± 3.4 0.659
    (SD score) –0.10 ± 1.2 –0.17 ± 1.2 0.569
Waist circumference
    (cm) 80.2 ± 8.9 76.6 ± 7.9 0.001
    (SD score) 0.24 ± 1.1 0.73 ± 0.92 0.001
Hip circumference
    (cm) 92.1 ± 8.1 94.2 ± 9.4 0.017
    (SD score) –0.22 ± 1.2 0.025 ± 1.1 0.037
Waist-to-hip ratio 0.87 ± 0.054 0.82 ± 0.063 0.001
Waist-to-hip ratio (SD score) 0.72 ± 0.92 0.90 ± 0.93 0.055
Sum of skinfold thicknesses
    (mm) 41.3 ± 20.6 62.6 ± 22.4 0.001
    (SD score) 1.7 ± 2.8 1.1 ± 1.6 0.012
a The sample size was slightly less for some variables. 
b Two-sample t tests. 
c x ± SD (all such values).
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Early postnatal weight gain and late infancy weight gain were both positively associated 
with height, weight, BMI, and waist circumference (SD scores), fat mass, fat-free mass, and 
percentage body fat at age 19 y. Late infancy weight gain was also positively associated with 
the adult sum of skinfold thicknesses (SD scores). The coefficients of waist circumference, fat 
mass, and fat-free mass in relation to early postnatal and late infancy weight gain diminished 
after correction for current height (SD scores) but remained significant. When adjusted for 
target height (SD scores), the associations between prenatal, early postnatal, and late infancy 
weight gain and adult height (SD scores) remained significant but decreased in magnitude. 
No significant associations were found between early postnatal and late infancy weight gain 
and the waist-to-hip ratio (SD scores) or subscapular-to-triceps ratio in young adulthood. 
No significant interaction was found between birth weight (SD scores) and early postnatal 
weight gain or between birth weight (SD scores) and late infancy weight gain with regard 
to any of the outcome measures at age 19 y. Correction for race, socioeconomic status, sex, 
and physical activity did not significantly change the results of the abovementioned analyses 
(data not shown). 
Relative contributions of weight gain during different time periods
For the anthropometric outcomes at age 19 y that were associated with weight gain during 
early life, the percentages of variance explained by weight gain during the different time 
periods are presented in Table 4. For current height (SD scores), 37.5% of the variance 
was explained by target height (SD scores). Birth weight explained 6.2% of the variance in 
current height not explained by target height, whereas early postnatal weight gain explained 
another 4.5% of current height variance not explained by target height or birth weight. 
Late infancy weight gain explained 3.3% of the variance of current height not explained by 
the abovementioned variables. So, for current height (SD scores), adjusted for target height 
(SD scores), the largest change in R2 values was observed for the effect of birth weight (SD 
scores). 
For adult weight, the effect of birth weight on R2 change equaled the effect of early postnatal 
weight gain. For BMI and waist circumference (SD scores) and fat mass, fat-free mass, and 
percentage body fat, the largest increase in R2 - apart from adjustments for sex and current 
height (SD scores) - was observed with the input of early postnatal weight gain into the 
model. The percentages of variance explained by early postnatal and late infancy weight gain 





This study describes the results of a large-scale prospective study on the relation between birth 
weight, postnatal weight gain, and anthropometric variables at the age of 19 y in subjects 
born very preterm and provides exclusive information about the predictive value of weight 
gain during the first 2 trimesters of pregnancy for adult body composition. 
In our study there might have been an interference of the effects of possible programming 
(ie, the lifelong changes in structure or function of body systems that follow a specific insult 
in early life) and the effects of prematurity on BMI and body composition in young adulthood. 
We studied only children with a gestational age <32 wk and corrected birth weight for 
gestational age, which facilitated a valid comparison within the cohort. The results may 
not be generalizable to infants born at term but do provide useful information about fetal 
growth restriction in infants born very preterm. We did not separately address the effect of 
gestational age on adult outcomes, because this interesting issue provides sufficient data for 
a different study. 
Inherent to the population studied, perinatal mortality was high, especially in those infants 
with a shorter gestational age and to a lesser extent in those with a lower absolute birth 
weight. However, no significant difference in birth weight (SD scores) was found between 
those who died and those who survived; therefore, confounding by selective mortality seems 
unlikely. The same reasoning can be applied to the response and the nonresponse groups. 
Some subjects had missing data on weight at 3 mo or 1 y, but these missing data were not 
related to any of the outcome measures. 
We found some differences between anthropometric characteristics at age 19 y between the 
male and the female participants. Whereas the differences in absolute values were expected, 
the different SD scores for a few outcomes were not. However, because these sex differences 
were found in unplanned post hoc analyses, the results should be interpreted very cautiously. 
Adjustment for sex did not change the conclusions of the study. 
To determine fat mass and distribution we used skinfold thicknesses, which are known to 
be prone to interobserver variation.38 However, although skinfold-thickness measurements 
tend to overestimate fat mass somewhat compared with a direct method such as dual-
energy X-ray absorptiometry (DXA), Fewtrell et al39 concluded from their study on 
prematurity and body fatness at ages 8–12 y that the same associations were found with 
both methods. The correlations between the anthropometric data of Durnin and dual-
photon absorptiometry are 0.76 and 0.83 for males and females, respectively.40 A study 
of the reproducibility of the skinfold-thickness measurements used in the POPS-19 study 
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showed that the reliability of the skinfold-thickness measurements was relatively low, but 
the reliability of the derived estimates of body composition was much higher (intraclass 
correlation coefficients ranged from 0.55 to 0.98), with a high intraobserver reliability 
(intraclass correlation coefficient > 0.99) (AM Euser, MJJ Finken, S le Cessie, JM Wit, FW 
Dekker, unpublished observations, 2004). Because the birth weights of participants did 
not substantially differ between centers, this relatively low interobserver reliability will 
have only attenuated the associations between birth weight and body composition at age 
19 y. 
We found that birth weight was positively associated with weight, height, and BMI at age 
19 y. These findings are consistent with those of studies in populations born at term.11,12 Our 
study indicates that the positive association between birth weight and adult BMI is determined 
as early as the first 2 trimesters of pregnancy. This finding conflicts with the results of the 
Dutch famine studies, which suggest that maternal malnourishment during early gestation 
predisposes to later obesity in the offspring.7,8 Our study does not confirm the J- or U-shape 
relation between birth weight and adult BMI found in some studies,13,41,42 which might form 
a biological link between low birth weight and adult diseases. This suggests that either the 
associations mentioned above are established during the third trimester of pregnancy or that 
there is another link between fetal growth and adult disease. Singhal et al18 proposed that 
this link might be formed by fat-free mass. However, though fat-free mass was significantly 
associated with birth weight, our data show no significant association between birth weight 
and percentage body fat in adulthood. 
Although prenatal weight gain was not associated with percentage body fat, more early 
postnatal weight gain was associated with both a higher BMI and a higher percentage body 
fat at age 19 y. The higher BMI found agrees with the findings of earlier studies in which a 
positive association between early growth and adult BMI and obesity was found.13,43 Our 
study showed that this association was independent of birth weight and that the higher BMI 
was partly accounted for by a higher percentage body fat, at least in premature infants. So 
far, only a few studies have addressed the relation between early growth and adult fat mass 
and distribution. From our results it may be concluded that the positive associations found by 
Ong et al6 and Stettler et al24 between early catch-up growth and fatness in childhood persist 
into young adulthood. This agrees with a study by Li et al25 about early postnatal growth in 
length and adult fat-free mass in a Guatemalan population. 
Moreover, we also found that a greater postnatal weight gain was associated with a higher 
adult waist circumference, both when adjusted and unadjusted for current height (SD scores). 
Fetal weight gain was also positively associated with waist circumference (SD scores), but 
after adjustment for current body height (SD scores), the association completely disappeared; 
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this finding indicates that the increase in waist circumference with higher birth weight reflects 
mainly an increase in body size and not solely an increase in visceral fat. Prenatal and postnatal 
weight gain were not significantly associated with waist-to-hip ratio or subscapular-to-triceps 
ratio, although a tendency for low birth weight to be associated with a higher waist-to-hip 
ratio and a subscapular-to-triceps ratio was observed. This finding agrees with the results 
of Fall et al13 and Li et al25. In some studies, low birth weight and early growth have been 
associated with a more truncal and abdominal fat pattern13,16,17 but only after adjustment for 
current BMI. Although adjustment for current body size in fetal origins studies should always 
be interpreted cautiously, it might be arguable for some adult disease outcomes.44 However, 
we think it is theoretically incorrect to adjust for current BMI -which includes current fat mass- 
in analyses with fat mass and fat distribution as outcomes. If correction for current body 
proportions is applied, an index independent of body fat should be used. 
The associations found between birth weight, early postnatal weight gain, and late 
infancy weight gain and adult BMI and body composition might be explained by perinatal 
programming.45 However, it is also possible that genes that influence prenatal, perinatal, 
and adult determinants underlie the associations found. More research is required about the 
possible mechanisms of programming of body proportions and body composition. 
In conclusion, gestation, the period from birth until 3 mo postterm, and the period from 3 
mo until 1 y postterm seem to be important predictors of body size and body mass in young 
adulthood in infants born very preterm. Greater weight gain during these periods is associated 
with greater height, weight, BMI, and fat-free mass at age 19 y. Birth weight in infants born 
very preterm is not associated with fat distribution. However, early postnatal weight gain and 
late infancy weight gain are -independently of birth weight or current height- associated with 
a more abdominal pattern of fat distribution and a higher percentage body fat. The relative 
effect of weight gain from birth until 3 mo postterm on adult fat mass and fat distribution is 
more pronounced than is the effect of weight gain from 3 mo until 1 y postterm. 
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The general aim of the studies described in this thesis was of two sorts; in the first place to 
study the effects of prenatal and early postnatal growth on various adult health outcomes in 
individuals born preterm or with a low or very low birth weight, and in the second place to 
address methodological issues closely related to early origins of adult disease studies. In this 
chapter we will consider the results found in these studies in a more extensive perspective, 
both theoretically and clinically. At first, we will reflect on the broad scope of definitions, 
associations, and pathology that lies behind the term ‘metabolic syndrome’. Next, we will briefly 
relate this to the early origins hypothesis and its putative underlying etiological mechanisms. 
Subsequently, we will consider the sequence of posing research questions, building regression 
models, and interpreting results in early origins studies. This will be followed by several 
methodological issues inherently intertwined with the populations studied, after which we 
will address our main findings in relation to the recent literature about these topics. Finally, 
clinical relevance and future research perspectives will be discussed.
A metabolic syndrome?
The metabolic syndrome and some of its separate components form important outcome 
measures in our clinical studies in the HUNT and POPS populations. However, at first glance it 
becomes evident that this so called metabolic syndrome has no universally accepted definition, 
and that a confusion of tongues seems to exist. Numerous names and definitions coexist 
for the syndrome, of which those of the World Health Organization, the American Heart 
Association, the International Diabetes Federation, and the National Cholesterol Education 
Program are most widely used.1-4 While those definitions agree in considering central obesity, 
impaired glucose tolerance, dyslipidemia, and hypertension as essential components, they 
differ about corresponding cut-off levels, for these traits are all continuous variables artificially 
cut into the binary variable physiological versus pathological. Besides, the definitions differ in 
the algorithm used to cluster components to a syndrome, in how to measure glucose tolerance 
and obesity, in the appliance or non-appliance of different cut-offs for anthropometric values 
in different ethnic populations, and in the inclusion of the additional components micro-
albuminuria in the WHO definition.1 The result of this excessive number of definitions is a 
decreased generalizability of results found, and a thwarted comparison of the prevalence of 
the metabolic syndrome in different populations, for prevalences in the same population vary 
impressively depending on the syndrome definition used.5,6 
The original WHO definition of the metabolic syndrome is unique in the inclusion of 
microalbuminuria,1 which is the earliest clinical manifestation of obesity-associated kidney 
Chapter 9
132
damage and diabetic nephropathy in humans. The association between the kidney, obesity, 
and the metabolic syndrome is complex and might be pathologically mediated by both type 
II diabetes and hypertension.7 Though not undisputed, microalbuminuria has repetitively 
been found as a marker of insulin resistance and glucose intolerance that becomes evident 
before diabetes, and may thus serve as a marker of disease activity.8 However, even in non-
diabetic adults the metabolic syndrome has been shown to be independently associated with 
an increased risk for chronic kidney disease.9 So, apart from functioning as a complementary 
marker of insulin resistance only, the damaged kidney has a dual role with regard to the 
metabolic syndrome. This might be due to the fact that the kidney is closely associated 
with hypertension as well. On one hand, the kidney can raise blood pressure by several 
mechanisms hence provoking hypertension, while on the other hand hypertension aggravates 
the progression of renal disease.10 This hypertension found in obesity, another component of 
the metabolic syndrome, appears to be closely linked to abnormal kidney function caused by 
simultaneous activation of the renin angiotensin system, of the sympatic nerve system, and 
by physical compression of the kidneys when visceral obesity is present.7 However, despite 
increased pathophysiological understanding, the precise interaction between the kidneys and 
the metabolic syndrome has not been unraveled yet. 
In the pediatric field as well a tangle of definitions for the metabolic syndrome used in parallel 
exists, with the definition of the International Diabetes Federation being the most recent 
one.11 This abundance is not surprising, for in children and adolescents defining ‘the metabolic 
syndrome’ is even more complex than in adults. In the first place, several components of the 
syndrome, e.g. waist circumference and blood pressure, increase with age, and part of them 
are also influenced by puberty, like fat distribution and insulin sensitivity.12 Secondly, the end 
points for which the syndrome might give an increased risk are still far away in time and usually 
do not occur until in late adulthood. Therefore, direct evidence for the predictive value of the 
syndrome in childhood for increasing the risk of adult cardiovascular death or even disease 
is lacking, and instead only surrogate end points are reported.13 However, the international 
increase in overweight and obese infants and adolescents14 has lead to an urge to define the 
syndrome in this young and dynamic population as well, and numerous definitions coexist.15 
Partly, the problems mentioned above have been resolved by classifying children into age groups 
with different definitions, and by using age- and sex-specific percentiles or Z-scores in most 
definitions.15 However, it should be stressed that anthropometric reference charts generally 
have a descriptive origin and not a normative one, so when the population as a whole becomes 
more obese during the years, the same percentile lines represent increased BMI values. This has 
been clearly shown in the Netherlands between 1980 and 1997.16 This knowledge should be 
kept in mind when defining which percentile should serve as cut-off point. Besides, as reference 
charts tend to result from cross-sectional data collection, the inter-individual variance in the 
onset of puberty is intertwined in the reference values of individual ages. 
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The reason that ‘The Metabolic Syndrome’ as such does not exist, neither in adults nor in 
children, is partly inherent to it being a syndrome, as the definition of a syndrome is rather 
vague. The word ‘syndrome’ in Greek means ‘the confluence’, and this confluence is the only 
basis of a syndrome, which is usually defined as: “a symptom complex of unknown etiology, 
which is characteristic of a particular abnormality” (MeSH term), or: ‘a pattern of multiple 
anomalies thought to be pathologically related’.17 However, while the etiology per definition 
is still unknown in the initial decision of calling a constellation of symptoms a syndrome, 
it is implicitly expected that this unifying pathological relation will be found in subsequent 
research. Nevertheless, a satisfying unifying pathological base for the metabolic syndrome has 
not yet been found, despite intensive research, while the concept of the metabolic syndrome 
has been used for decades.18 Various hypotheses have been postulated, of which the insulin 
resistance hypothesis with glucose intolerance as central key player to explain the pathology 
of the other features of the syndrome is the most profoundly worked out and generally 
accepted one.19 However, it is possible to have the metabolic syndrome without being insulin 
resistant, and the association of insulin resistance with some of the other components of the 
syndrome is rather weak, while other more closely related features are excluded from the 
definition.20 Other complementary and alternative hypotheses with a more prominent role 
for central obesity,3 inflammation,21 or neurobiology22 have been proposed, but have not led 
to a satisfying single underlying etiology, which is, together with the ill-defined dichotomous 
criteria, grist to the mill of the opponents of the existence of a metabolic syndrome.20,23 
In addition to the physiologist’s point of view from which a unitary causation is lacking, the 
metabolic syndrome is also criticized from an epidemiologist’s point of view. Regardless if the 
expected common etiology has already been unraveled or not, the practical usefulness of 
working with a syndrome construct is the improved prediction of disease or complications 
compared with the sum of its separate components. And this, in turn, can be used in policy 
making and daily clinical practice. Originally, the metabolic syndrome has been defined 
because it should predispose to diabetes and cardiovascular disease (CVD).1 Indeed, the 
metabolic syndrome is associated with an increased risk of type two diabetes.24,25 However, 
as impaired fasting glucose, impaired glucose tolerance, or even overt diabetes form all 
components of the different definitions, this finding does not really strike like a bolt from 
the blue. The metabolic syndrome predicts future cardiovascular events in men and women 
as well.6,26 But again, objections can be raised; in the first place, the various definitions of 
the metabolic syndrome do not seem to predict better than existing risk scores for Cardio 
Vascular Disease (CVD) like the Framingham risk score.27,28 And more important, they do not 
predict better than the sum of the separate components.5,29,30 As the syndrome is composed 
of components which do all form well established, undisputed risk factors for CVD, a more 
than additive risk in case of clustering of components ought to form the mere advantage 
of taking them together in one definition. Taken all this criticism together, the usefulness 
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of the concept “metabolic syndrome” for the clinician seems to be little, as establishing the 
diagnosis improves neither pathophysiological understanding nor clinical utility. 
While indications for a common underlying etiology of the metabolic syndrome are often 
searched for in basic research as in animal models, or statistical models like factor analyses, 
another form of circumstantial evidence can be found in the classical logic form of modus 
tollens, i.e. “denying the consequent”. In science this form became well known when it was 
used by Karl Popper, who postulates that falsifiability is a prerequisite for a scientific theory. 
And though no rockbottom of knowledge exists, the best theory is that with the highest 
empirical content combined with the highest degree of corroboration.31 With our study on 
the metabolic syndrome in the HUNT we tested the hypothesis that the metabolic syndrome 
is a true syndrome with one common underlying etiology. If this first premise is true, the 
second premise is that all components of the metabolic syndrome should show the same kind 
of association with this underlying cause. Part of the underlying etiology of the metabolic 
syndrome - including that of the insulin resistance component – is likely to be formed by 
early life experiences, for small but recurring effects have been found for several of the 
separate components e.g. hypertension and glucose intolerance.32,33 In that case all separate 
components of the metabolic syndrome should have the same kind of association with an 
early life parameter, e.g. birth weight. However, we found several statistically significant 
but inconsistent associations of birth weight with the separate components of the so called 
metabolic syndrome. Though alternative explanations are imaginable, this result does not 
corroborate the metabolic syndrome as a true syndrome with one single underlying etiology. 
Early origins
Underneath this level of epidemiological associations, several mechanisms have been proposed 
with regard to the explanation of the replicated associations between early growth and various 
adult metabolic diseases. Typically, the major contrast is formed by the ‘thrifty phenotype’ 
hypothesis which was first postulated by Barker et al. on one hand, and the ‘thrifty genotype’ 
hypothesis on the other hand. In the first theory, the fetus is thought to adapt to intrauterine 
shortage of nutrients by a reduced capacity for insulin production by the pancreas, and insulin 
resistance, which results in reduced somatic growth in utero, and subsequent an increased 
adult disease sensitivity when growing up in a nutrient rich postnatal environment.34 In the 
second theory, reduced insulin-mediated fetal growth and adult insulin resistance, type II 
diabetes, and disease susceptibility are all regarded as phenotypes corresponding to the same 
insulin-resistance genotype.35 Adjacent to these two opposites, other hypotheses have been 
generated, like the “catch-up growth” hypothesis in which early postnatal catch-up growth is 
thought to be the pathogeneous link between fetal and adult life by causing over-activation of 
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the IGF system which in turn will result in secondary insulin resistance.36 Further, in the “fetal 
salvage” hypothesis the importance of insulin resistance is stressed while in contrast to the 
fetal insulin hypothesis beta cell hypoplasia is not thought to play a role in the development 
of adult disease in this theory.37 Finally, also increased fetal exposure to cortisol mediated 
by decreased maternal enzyme activity is suggested to connect low birth weight and adult 
disease, especially hypertension.38 
Recently, there is increasing evidence that epigenetic mechanisms, which concern the 
regulation of gene activity without affecting the genetic DNA code itself, might underlie the 
associations between early life parameters and adult disease. Epigenetic mechanisms tend to 
be gene specific and cell specific, and though it is unclear when they exert their effects on 
human developmental plasticity and subsequent disease susceptibility, this window might 
well extend from before conception until early postnatal life.39 Though much has still to be 
unravelled about epigenetic mechanisms and their role in the early origins of adult disease, 
they might well form a union between in former partly contradicting hypotheses. 
Methodological reflections
Originally, only the effect of birth weight as a proxy for prenatal growth and influences on 
adult health outcomes was presented,40 which is quite straightforward. However, it is well 
known that adult metabolic outcomes, e.g. blood pressure, are strongly positively associated 
with current adult weight.41,42 Besides, birth weight and subsequent adult weight are also 
positively associated.43 With this triad of associations in mind, researchers have subsequently 
almost invariably adjusted associations between birth weight and adult outcome for current 
adult weight with different explanations. Some of them just do so without any explanation,44 
most of them consider current weight or BMI as a potential confounder.45
Subsequently, a debate arose about whether this adjustment for current weight in early origin 
studies was justified, for it might well be an intervening variable in the causal pathway. This 
controversy was fuelled by Huxley et al. who showed in a meta-analysis that there was little 
or no relationship between birth weight and adult blood pressure without adjustment for 
current weight. She postulated the extreme statement that “adjustment for current weight 
might produce a spurious inverse association even if birth weight and current blood pressure 
are uncorrelated”.46 Theoretically, this situation might indeed occur as described more formally 
by Hernán et al. who propagate the use of causal diagrams to encode a priori subject matter 




Finally, Lucas et al. transposed the main point of the discussion from the interpretation of the 
changing prenatal weight component to the interpretation of the current weight component. 
The effect of adding current weight into a regression model with early weight and adult 
outcome is intricate. Lucas et al. suggests that such a model should be interpreted as the effect 
of change in weight between birth and adulthood (postnatal centile crossing), rather than the 
effect of restricted fetal growth.48 Moreover, it might be that especially those individuals with 
the lowest birth weights and the highest postnatal weight change have the highest changes 
on adult diseases.49,50
A well defined research question should be considered before building and interpreting any 
model. Given that the relationship between adult weight as such and adult metabolic diseases 
has already been sufficiently established, three separate research questions remain. The first 
one is the one it all started with: what is the effect of birth weight on adult disease? We 
think it theoretically unjustified to adjust for current adult weight in assessing this association, 
for adult weight is situated in the causal pathway. Birth weight is a proxy measurement of 
a dynamic process; prenatal growth (which once more might be considered to be a proxy 
variable as well, but this falls beyond the scope of this discussion). Birth weight itself alters at 
the very first day of life, as weight changes rapidly in small infants. Therefore, this potential 
risk indicator for adult disease should exert its effect through other, biological pathways. Adult 
size - which is as well a measurement of growth, though postnatal - might be one intervening 
mechanism, as it is related to birth weight. Since small infants tend to be small adults and 
large adults have an increased risk ofadult metabolic disease, statistical ‘adjustment’ for adult 
size will incorrectly inflate the association between birth weight and adult disease.
The second question is: what is the effect of postnatal growth on adult disease? As we first 
started with determining the effect of birth weight on adult disease, this subsequent question 
should be refined to: What is the effect of “growing more than expected from a given birth 
weight” on adult disease? Therefore in this case it is theoretically justified to build a regression 
model with adjustment for the effect of birth weight in the statistical model, because the 
effect of birth weight is known, it lies earlier in time, and we are not longer interested in it 
for this new, second research question. However, one should not look at the coefficient of 
birth weight in this model, let alone interpret it, for it is meaningless. If one wants to interpret 
both separate research questions in one model, one should use our proposed unexplained 
residual model. 
Finally, the third question is: does the effect of postnatal growth on adult disease differ 
between subjects with a low or a high birth weight? In this case a third model should be built 
with a third variable to test statistical interaction and one should look at all three coefficients 
for a proper interpretation of the results found. In this case we especially propagate the 
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unexplained residual model in contrast to the model of Lucas et al., for the former does not 
assume an underlying quadratic relation between birth weight and adult disease anymore. 
This question should be investigated, even if with the first question no association has been 
found, for the effects found in smaller subgroups might be overruled by the main group 
analysis.
Reliability 
Another problem frequently encountered, especially in multi-center studies, is the reliability 
of measurements. In our studies about reliability we try to provide practical approaches for 
two problems: reliability indicators and log transformed variables, and the assessment of 
reliability in a small study within the context of a large clinical study. It should be stressed that 
especially the latter should not be regarded as an illegitimate statistical “solution” to improve 
the reliability by inflating it’s coefficient, like estimating an intra-class correlation coefficient 
in a much more heterogeneous population than the study population it will be used in. On 
the contrary; the point estimate of the reliability coefficient remains exactly the same, but 
the precision of the estimate improves, or, if one takes the point of view that this precision 
could also be effectuated by increasing the number of subjects in the reliability study, the 
efficiency increases. Still, the clinical question about the reliability of skinfold measurements, 
and consequently the accuracy of its use in the POPS-19 study, remains open. At this point 
the methodological and clinical studies confluence and the reliability study shows that the 
reliability of the solitary skinfold measurements was poor. The sum of the four skinfolds 
however, had a better reliability and therefore this measure was subsequently used in the 
POPS-19 study to calculate the corresponding fat percentage, to which end it was first log 
transformed. At last, the decision if in situations like this special reliability indicators for log 
transformed variables are needed, should always be based solely on the (skewed) distribution 
of the errors and not of the distribution of the variable itself. 
Population related issues
The populations in which the main effect on adult health outcomes is expected to be 
found consist largely of infants with a low birth weight or born preterm. However, analyses 
in this population are complicated at different levels, most of methodological origin. The 
major problem is formed by different definitions applied in the literature to form a cohort; 
classification by gestational age51 or by birth weight.52 This has important consequences for 
the subsequent postnatal growth characteristics in the cohorts formed. Besides, no consensus 
has been reached about the optimum reference grow chart,53 which complicates comparisons 
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both between different preterm study populations, and comparison with infants with normal 
birth weight and gestational age range. Finally, as improvements in neonatal care have only 
recently facilitated the survival of very preterm and very low birth weight infants, systematic 
literature about the consequences of early growth in adulthood is lacking in this population 
thus far. 
Together with others,54 we suggest classification of small infants by gestational age, for in this 
population this is a better predictor of survival than birth weight.55 Next, in every gestational 
age category a classification of appropriate for gestational age (AGA) or small for gestational 
age (SGA) can be made. For an optimal distinction between AGA and SGA, preferably an 
up-to-date growth chart from the same population should be available. To avoid bias of 
non-random missing data at lower gestational ages, when the timing of delivery is strongly 
related to poor growth, a combination of anthropometry of live born infants and intra-uterine 
ultrasound growth estimates of fetuses of the same gestational age not born yet has been 
proposed.53 However, fetal ultrasound has systematic and random inaccuracies, which seem 
both to be related with birth weight.56
Taken in account these limitations encountered early in the follow up of cohorts of low birth 
weight or preterm subjects, new problems are likely to accumulate in the same cohorts at 
adult follow up. First, selection bias might be introduced by a high mortality in the perinatal 
period leading to selective survival. In the POPS cohort, 27% of the infants died within the 
first year of life,55 and 28% were deceased before the age of 19 years.57 The in-hospital 
mortality was strongly associated with gestational age, and hence with the incidence and 
severity of the respiratory distress syndrome.55 It is plausible that metabolic parameters 
affecting perinatal survival also affect the metabolic profile, including body composition, at 
age 19. For example, while in small infants born very preterm hypoglycemia and hypotension 
are important life threatening conditions to overcome, at age 19 right the opposite conditions 
of insulin resistance and hypertension are considered to be a health disadvantage. At low 
gestational ages and low birth weights, infants with a protective metabolic profile will have 
a better survival, while at higher gestational ages and birth weights metabolic profile does 
not influence survival anymore and infants with all metabolic profiles will have equal changes 
to survive till age 19. However, while selective mortality might form an explanation for 
associations found, it should not be considered as a bias in this case, for survival until adult 
age is a prerequisite for developing disease at adult age, and hence might be considered to 
be ‘in the causal pathway’ of low birth weight and adult disease. 
A second issue, closely related to the first, might affect both the internal and internal validity 
of studies in the cohort. This concerns the effect of medical treatment on survival and the 
changes in neonatal care during the years. One keystone of treatment of infants born very 
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preterm is antenatal corticosteroid (betamethasone) administration, which significantly 
reduces neonatal mortality (RR 0.69, 95% CI 0.58 to 0.81).58 Antenatal corticosteroids exert 
a major effect by reducing the incidence of Infant Respiratory Distress Syndrome (IRDS), but 
the effects are likely to be pleiotropic, possibly also affecting metabolic systems 59,60. In this 
way its use in certain individuals could have changed the effects of the selective survival 
of certain metabolic profiles as described above. While the first trial with corticosteroids in 
humans took place in 1972,61 the first structured review about this subject was published 
only in 1990.62 This means that in 1983 when the POPS cohort was started, the prescription 
of antenatal corticosteroids was still dependent on the personal views of the gynecologists. 
However, it does not seem likely that this non-randomized allocation of a treatment has led 
to confounding, for it was random with regard to other risk factors that may have influenced 
the outcome studied, i.e. metabolic profile. 
Nowadays antenatal corticosteroids are standard treatment in impending preterm delivery 
and synthetic surfactant has a widespread application after its initial introduction in the early 
1980s.63 Compared with the POPS cohort of 1983, this has led to an increase in survival of 
very preterm infants, but not in a change in disease free survival, because at present, the 
sicker infants survive as well.64 For this reason the generalizability of the results found in 
studies in the POPS cohort, including those in this thesis, to the current generation of infants 
born very preterm is unclear. While for the incidence of handicaps or bronchopulmonary 
disease a distinct trend can be shown, this is harder to predict for the adult metabolic 
outcomes. While on the one hand the availability of surfactant has decreased the importance 
of pulmonary function to survive the first days of life and thereby placing more weight on the 
importance of a suitable metabolic profile of the neonate to survive, on the other hand the 
effect of antenatal corticosteroids is likely to be more pleiotropic as explained above and act 
on both pulmonary and metabolic systems. However, it is inherent to the introduction of a 
new treatment that the long-term effects, both intended and unintended cannot be studied 
until late future has turned into present. 
Finally, selection bias could have been introduced by a low response rate, which was the 
case in both the POPS-19 and the HUNT 2 studies. In POPS non-response was associated 
with male sex, non-Dutch origin, low maternal education, and severe handicaps,57 while 
in the HUNT study the main reasons for non-participation in the age group studied were 
having moved out of the county or lack of time.65 However, in neither of the two studies 
non-response was associated with birth weight or gestational age. For this reason, as an 
association with determinant i.e. birth weight and non-response is lacking, non-response 




Apart from all these deliberations, an interesting remaining question is whether differences 
found in the association between early growth and adult metabolic disease in the POPS 
population compared with the HUNT study might be (partly) explained by the prematurity 
of the first subjects. It would be tempting to say so, for the mean gestational age forms a 
major difference between the two populations and unfortunately a control group for the 
POPS has never been recruited in the past. But, on the other hand, gestational age is not the 
only difference between the populations, apart from the age of the adult health assessment, 
the studies are also conducted in two different countries i.e. the Netherlands and Norway. To 
distort the hypothesized effect of prematurity on the association between early growth and 
adult disease, factors that differ between the different countries should have an influence on 
both prematurity and the relation between early growth and adult disease. One of the most 
important factors that might have these specific multiple effects will be the national level of 
prosperity that among others will work through in the mean birth weight, quality of neonatal 
care, and the development and treatment of adult diseases as well. This national level of 
prosperity, for example expressed as the gross national product, is similar, so it is not likely to 
overshadow the possible effect of prematurity in this context. However, as the level of overlap 
between the two populations was too limited for proper comparison – only 28 very preterm 
subjects in the HUNT, we can not be certain. 
Main results in relation to the literature 
With regard to prenatal growth and the adult metabolic syndrome, we found that birth 
weight was inconsistently associated with the separate components of the syndrome in 
men and women. In general, these findings are in agreement with recent systematic reviews 
about the association between birth weight and these individual outcomes.32,66-70 However, 
contrary to most previous findings66,71-76 we did not find a significant association between 
low birth weight SDS and the metabolic syndrome as a composite construct. There are 
several explanations for this discrepancy. First it might partly be explained by publication bias. 
Second, inappropriate statistical adjustment for current weight or BMI was applied in several 
studies25,75 66 as we explained in chapter 6. Third, in these previous studies often only separate 
components of the metabolic syndrome were analyzed, while in the conclusions report about 
‘the metabolic syndrome’.72-74 All together, this weakens the validity of low birth weight as a 
unifying risk factor for the metabolic syndrome. 
We found that IUGR was associated with low-normal kidney function in young adults from 
the general population. This is consistent with a recent systematic review of observational 
studies (including ours) in which an Odds Ratio of 1.8 was found for the effect of low birth 
weight on low adult glomerular filtration rate. This effect size was relatively consistent for 
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other renal outcomes reviewed like end stage renal disease or albuminuria.77 Our results are 
also in agreement with findings in subjects born very prematurely from the POPS cohort.78 
A pathological basis supporting these clinical findings has been found in autopsy studies in 
which a low nephron number was observed in low-BW subjects.79-81
Regarding the effect of early growth on adult body composition we found in infants born 
very preterm that prenatal growth was positively associated with weight, height, and BMI at 
age 19; i.e. mainly with body size. These findings are consistent with studies in term born 
populations43,82 and indicate that the positive association between birth weight and adult BMI 
is already determined in the first two trimesters of pregnancy. We did not confirm the J- or 
U-shape relation between birth weight and adult BMI found in some other studies.45,83,84 This 
suggests that either these associations are established during the third trimester of pregnancy, 
or that there is another link than BMI between reduced fetal growth and adult disease. Fat-
free mass has been proposed,85 but our data do not support this. More early postnatal weight 
gain however, was associated with both a higher BMI and a higher percentage body fat at age 
19 y. Our results confirm studies in adults,83,86,87 and it may be concluded from our data that 
the positive associations found between early catch-up growth and fatness in childhood88,89 
persist into young adulthood. Our study adds that the higher BMI found was partly accounted 
for by a higher percentage body fat, at least in premature infants, and that the association 
was independent of birth weight. Finally, we also found that a greater postnatal weight gain 
was associated with a higher adult waist circumference, both when adjusted and unadjusted 
for current height (SD scores). This finding agrees with the results of Fall et al83 and Li et al.86 
In some studies, both low birth weight and early growth have been associated with a more 
truncal and abdominal fat pattern83,90,91 but only after adjustment for current BMI. Again, we 
think it is theoretically incorrect to adjust for current BMI -which includes current fat mass- in 
analyses with fat mass and fat distribution as outcomes. 
Clinical relevance and future perspectives
In contrast with the methodological studies that can be applied directly in future research, 
the clinical studies in this thesis are mainly of a descriptive nature. With regard to the effect 
of prematurity a less favorable adult body composition was found, while low birth weight 
was associated with reduced kidney function and a slightly less favorable metabolic profile 
at young adult age. Therefore, prevention of prematurity and low birth weight should be 
stressed. However, when prematurity or low birth weight is already an accomplished fact, 
the focus should be on systematic screening of these infants and adults for the sake of 
prevention, life style advices, and early treatment of metabolic diseases. With regard to 
recommendations about early catch-up growth even more caution is warranted, for at first 
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place it is not proven that preventing this catch-up growth in low birth weight or (very) preterm 
infants also prevents adult metabolic disease and, more important, early catch-up growth is 
considered to be important for neurodevelopmental outcome.92-94 In general, growth should 
be considered as a proxy measurement for early life influences, not as the causal agent itself. 
In this context, the associations we found, though of small size, signify that lifelong effects of 
early life influences seem to exist in these specific populations as well, and that more research 
on underlying mechanisms is required. 
As mentioned before, the outcomes of the POPS-19 study might not be fully generalizable 
to the current generation of preterm infants. Therefore, ideally a new research cohort should 
be formed for a prospective study, with special attention for an appropriate term control 
group, prenatal ultrasound measurements, and drawing cord blood. However, follow-up in 
the POPS (and HUNT) should be continued as well, for age 19 is still young to develop a 
full blown metabolic syndrome, let alone cardiovascular events, and this should be studied 
at older age. At subsequent follow-up, new focuses could be the acquiring of DNA of sibs 
and parents for the role of genetics and epigentetics in prematurity, growth, and disease, 
and the reproduction and offspring of the POPS infants. An imaging technique like a DEXA 
body scan should also be desirable as part of this follow-up, to study more precisely the adult 
body composition of subjects born preterm, and in second place for the external validation 
of skinfold measurements in this population. A related issue that could be studied in this 
context is the supposed altered body composition of SGA and preterm subjects which seems 
to continue in adulthood that will exert an effect on the estimation of GFR by using formulas 
dependent on creatinin and body weight. Finally, when in the same subjects body composition, 
renal function, and possible intermediate hormones like adiponectin are assessed, this might 
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Cardiovascular disease forms a major health problem world wide and often results from an 
aberrant metabolic profile. Numerous studies have shown an association between low birth 
weight as an indicator of poor intra-uterine growth, and adult metabolic diseases like obesity, 
type 2 diabetes, hypertension, and cardiovascular incidents. According to recent hypotheses 
an interaction between genetic, epigenetic, and environmental influences leads to intra-
uterine programming of metabolic systems like the insulin system to become adapted to 
scarcity. This programming remains in postnatal life, leading to obesity and disease when food 
supply is abundant here. However, several unresolved questions in this field remain. In this 
thesis the effects of prenatal and early postnatal growth on metabolic disease at young adult 
age are addressed in both a population of subjects born at term, and in a population born 
very preterm, together with some closely intertwined methodological issues.
As infants born (very) preterm usually have a very typical growth pattern, the available 
literature about the growth of these infants until adulthood is reviewed in chapter 2. In 
the early postnatal period, they almost invariably show a substantial growth failure, which 
is usually followed by catch-up growth over two to three years. Generally, subjects born 
(very) preterm achieve a slightly shorter height and lower weight than term born peers at 
adulthood. Disproportionate catch-up growth in height and weight may lead to an altered 
body composition in adulthood, especially in females. While catch-up growth in this population 
is beneficial for neurodevelopmental outcome, recent literature indicates that it might have 
adverse effects on metabolic health in adult life.
In chapter 3 various (linear) regression models are compared to study the effect of prenatal 
growth - expressed as birth weight - and the effect of subsequent postnatal growth on adult 
health outcome simultaneously in one model. This method implicates a proper research 
question and a careful interpretation of the coefficients found. A regression model based 
on unexplained residuals resulting from the equation of predicting later growth from birth 
weight was preferred. In this model the regression coefficients of birth weight and later 
growth can both be directly interpreted in the same model, and besides this model doesn’t 
assume a quadratic relationship in testing for interaction between birth weight and later 
growth on adult disease.   
As in early origins studies probably small effects are searched for over a long time span during 
which a lot of variables like life style are likely to exert their effects on metabolic profile, large 
study populations are required. These are often characterized by a multi-center design in 
which accurate information about reliability of the measurements is very important, for low 
reliability might lead to bias or dilution of the results found. In chapter 4 a method is discussed 
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to optimize reliability studies by combining variance components found in a small reliability 
study with variance components found in the large multi-center itself when estimating intra-
class correlation coefficients. This method leads to a more precise and efficient estimation of 
reliability. 
When reliability indicators are log transformed because of a skewed distribution of errors, the 
interpretation of the indicators of reliability Bland-Altman method (BA) and Coefficients of 
Variation (CV) is not straight forward anymore. In chapter 5 practical methods are addressed 
to obtain meaningful parameters of reliability on the original scale of measurement by 
applying existing statistical methods in the field of reproducibility. Regarding BA plots anti-
logs are utilized for back transformation of log-transformed limits of agreement which can 
subsequently be plotted into the BA plot on original scale. CVs can be derived directly from 
the standard error of the log-transformed measurements.  
The metabolic syndrome is an adult health outcome that has been repeatedly associated with 
early growth, but has been almost never been analyzed as the entire syndrome in literature. 
In chapter 6 the association between birth weight and the metabolic syndrome according 
to international definitions was studied in a Norwegian population based prospective cohort 
study of males and females aged 20 to 30 years old (HUNT 2). It was found that the metabolic 
syndrome as a whole had no association with birth weight in females, and a small u-shaped 
association with birth weight in males, so a slightly increased risk for both a lower and a 
higher birth weight than the reference category. When addressing the separate components 
of the syndrome, various associations were found in both men and women, but of different 
directions. This might indicate that low birth weight is not a unifying etiological base for the 
metabolic syndrome, thereby also weakening the appropriateness of the metabolic syndrome 
concept. 
Another important organ that is likely to be influenced in its function by early life experiences, 
but not included in most metabolic syndrome definitions is the kidney. In chapter 7 this 
association between birth weight and kidney function was studied in the Norwegian cohort 
mentioned above. A small effect of low birth weight being associated with low-normal kidney 
function in young adulthood was found. This effect was stronger and more consistent in men 
than in women. 
In contrast to term born infants, in infants born (very) preterm growth during the first 
two trimesters can be estimated directly by measuring their birth weights, thus providing 
information about timing of early life influences on adult outcome. In chapter 8 the effects 
of prenatal and early postnatal growth on young adult body composition were studied in 
a nationwide Dutch cohort of infants born <32 weeks of gestation (POPS-19). For both 
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males and females, mean height and weight were below the means of the Dutch reference 
population of 19-year olds, while mean values for waist circumference, waist-to-hip ratio, and 
the sum of four skinfold thicknesses were greater than the Dutch population means. In these 
infants, weight gain before preterm birth was positively associated with adult body size, but 
not with fat mass or fat distribution. In contrast, more early postnatal growth was associated 





Samenvatting in het Nederlands
Hoofdstuk 1. Inleiding
Hart- en vaatziekten vormen wereldwijd een groot gezondheidsprobleem. Een belangrijke 
risicofactor voor het krijgen van hart- en vaatziekten is een afwijkend stofwisselingspatroon 
(metabool syndroom). Tot dit metabool syndroom behoren overgewicht - met name een te 
grote buikomvang -, een verhoogde bloeddruk, een verhoogde bloedsuikerspiegel en een 
verstoorde vethuishouding. 
Uit eerder onderzoek is bekend dat de kans op het krijgen van hart- en vaatziekten mede 
bepaald wordt door gebeurtenissen in het zeer vroege leven, zowel binnen als buiten de 
baarmoeder. Dit wordt de ‘early origins of adult disease hypothesis’ genoemd. Vroege 
groei, bijvoorbeeld uitgedrukt als geboortegewicht, is een belangrijke en goed meetbare 
afspiegeling van deze gebeurtenissen. Binnen het early origins onderzoeksveld zijn echter nog 
veel onbeantwoorde vragen. Ook de manier waarop early origins onderzoek methodologisch 
het best verricht kan worden is onderwerp van discussie.
Dit proefschrift betreft twee typen onderzoek. In een aantal hoofdstukken wordt het verband 
tussen vroege groei en het ontstaan van het metabool syndroom en daarmee samenhangende 
gezondheidsproblemen op jongvolwassen leeftijd onderzocht. Dit onderzoek vindt zowel 
plaats in een op tijd geboren populatie (de Noorse HUNT-studie) als in een populatie van veel 
te vroeg geborenen (de Nederlandse POPS-studie). Daarnaast is er een aantal hoofdstukken 
waarin ingegaan wordt op diverse methodologische vraagstukken die zich voordoen bij deze 
vorm van epidemiologisch onderzoek. 
Hoofdstuk 2. De groei van te vroeg geboren kinderen
Kinderen die veel te vroeg geboren zijn, dat wil zeggen na een zwangerschapsduur van minder 
dan 32 weken in plaats van 40 weken, vertonen vaak een kenmerkend groeipatroon. Het is 
bekend dat dit groeipatroon doorgaans afwijkt van dat van de normale populatie, maar deze 
groei van geboorte tot volwassenheid is nog nooit systematisch op grote schaal beschreven. 
Een vergelijking tussen de bestaande artikelen over de groei van te vroeg geborenen wordt 
bemoeilijkt doordat de Amerikaanse indeling van kleine pasgeborenen is gebaseerd op 
lichaamsgewicht in plaats van zwangerschapsduur zoals in Europa. 
In dit hoofdstuk wordt een systematisch overzicht gegeven van de bestaande literatuur over 
de groei van te vroeg geborenen tot aan de volwassenheid. In de periode kort na de geboorte 
vertonen deze kinderen nagenoeg allemaal een forse groeiachterstand. Vervolgens begint 
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de meerderheid van de kinderen aan een periode van inhaalgroei tot ongeveer het tweede 
à derde levensjaar. Uiteindelijk zijn veel te vroeg geboren kinderen zowel in hun kindertijd 
als in de puberteit wat kleiner en lichter dan hun leeftijdsgenoten die geboren zijn na een 
voldragen zwangerschap. Door een verschil in inhaalgroei in lengte en gewicht kan bij een 
deel van de kinderen een verstoorde lichaamssamenstelling ontstaan wat zowel kan leiden tot 
over- als ondergewicht. Dit lijkt vooral het geval te zijn bij meisjes. 
Het is aangetoond dat de vroege inhaalgroei gunstig is voor de neurologische ontwikkeling 
van veel te vroeg geborenen. Er zijn echter ook aanwijzingen dat dezelfde inhaalgroei 
ongunstig is voor het stofwisselingsprofiel op jong volwassen leeftijd. De literatuur hierover 
is echter nog zeer beperkt. 
Hoofdstuk 3. Een regressiemodel met ‘restgroei’ heeft de voorkeur in het analyseren 
van early origins of adult disease hypothesis vraagstukken 
Het effect van vroege groei op het ontstaan van het metabool syndroom op volwassen 
leeftijd kan worden onderzocht met behulp van een lineair regressie model. Deze aanpak 
is vrij rechttoe rechtaan. Indien echter naast het effect van vroege groei ook naar het effect 
van latere groei wordt gekeken, zijn er twee variabelen in het model. Deze zullen elkaar 
beïnvloeden, waardoor de uitkomsten van het model gemakkelijk verkeerd geïnterpreteerd 
kunnen worden. Het ligt namelijk voor de hand om het effect van latere groei te corrigeren voor 
vroege groei, aangezien latere groei wordt beïnvloed door vroege groei. Indien daarentegen 
naar het effect van vroege groei zelf wordt gekeken, is het theoretisch meestal onjuist om 
voor het effect van latere groei te corrigeren. Dit laatste gebeurt echter automatisch in een 
regressiemodel met twee variabelen. 
Eén oplossing voor dit probleem is om twee aparte regressiemodellen te gebruiken voor 
de twee afzonderlijke vraagstellingen. Eén met alleen vroege groei in het model voor het 
effect van vroege groei, en één met beide variabelen in het model voor het effect van latere 
groei, waarbij men dan de door het model gegenereerde uitkomst voor de vroege groei moet 
negeren. Dit is een nadeel van deze eenvoudige en overzichtelijke benadering met twee 
modellen.
Een tweede oplossing die wij in dit hoofdstuk beschrijven, biedt de mogelijkheid om beide 
uitkomsten voor vroege en late groei wel op correcte wijze uit één model af te lezen. Hiervoor 
wordt eerst met behulp van een regressiemodel late groei voorspeld vanuit vroege groei. 
Zo ontstaat een derde variabele, namelijk de ‘restgroei’ die overblijft als van de gehele late 
groei het effect van vroege groei is weggenomen. De restgroei, wiskundig beschreven als 
‘unexplained residuals’, is onafhankelijk van de vroege groei. Indien nu vroege groei en de 
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restgroei samen in één lineair regressiemodel worden gevoegd, kunnen rechtstreeks de juiste 
uikomsten voor zowel vroege als late groei op het ontstaan van ziekte op volwassen leeftijd 
afgelezen worden. Dit model is ontwikkeld binnen het kader van de POPS-studie, maar kan 
breed worden toegepast in toekomstige studies naar ‘early origins’ in andere populaties. 
Hoofdstuk 4. Reproduceerbaarheidsstudies kunnen efficiënter worden opgezet door 
variantiecomponten uit verschillende studies te combineren
Het effect van vroege groei op ziekte op volwassen leeftijd is vermoedelijk  klein. Dit effect 
wordt gemakkelijk overschaduwd door andere effecten zoals levensstijl, vooral omdat het 
metabool syndroom pas later in het leven optreedt. Om toch een mogelijk effect van vroege 
groei te kunnen aantonen, zijn vaak grote studies met verscheidene deelnemende centra 
nodig. In deze grote studies waarbij veel proefpersonen moeten worden onderzocht, wordt uit 
het oogpunt van effectiviteit vaak gekozen voor snelle en eenvoudige onderzoeksmethoden. 
De prijs die hiervoor soms betaald wordt, is een verminderde nauwkeurigheid van de bepaling, 
mogelijk veroorzaakt door verschillen in metingen tussen onderzoekers en tussen centra. 
Het is voor het beantwoorden van de oorspronkelijke vraagstelling: “is er een verband 
tussen vroege groei en het ontstaan van het metabool syndroom op volwassen leeftijd?” 
van groot belang om te weten hoe nauwkeurig de bepaling is verricht. Als er systematische 
verschillen tussen onderzoekers of centra gevonden worden, kan hiervoor gecorrigeerd 
worden. Indien er veel ‘toevalsvariatie’ tussen metingen gevonden wordt, geeft dit ruis in de 
gegevensverzameling. Als er vervolgens geen verband kan worden aangetoond tussen vroege 
groei en ziekte op latere leeftijd, wil men kunnen uitsluiten dat dit uitsluitend werd veroorzaakt 
door deze toevalsvariatie c.q. ruis. En indien er wel een verband wordt aangetoond wil men 
kunnen vermelden in welke mate dit mogelijk nog versterkt wordt indien er gecorrigeerd zou 
worden voor toevalsvariatie in de metingen. 
In een reproduceerbaarheidsstudie naar de herhaalbaarheid van metingen worden de 
verschillen tussen onderzoekers en centra vastgelegd. Vaak worden deze verschillen (meetfout) 
uitgedrukt in verhouding tot de verschillen tussen proefpersonen onderling (de echte 
verschillen waarin de onderzoeker geïnteresseerd is). In deze reproduceerbaarheidsstudies 
worden dezelfde proefpersonen meerdere malen gemeten door verschillende onderzoekers. 
In tegenstelling tot de grote studie zijn deze reproduceerbaarheidsstudies juist vaak 
kleinschalig van opzet, anders zou dit de gewonnen efficiëntie van de grote studie teniet 
doen. Tegelijkertijd is een bepaald aantal mensen vereist om nog betrouwbare uitspraken te 
kunnen doen, wat de nodige logistiek vereist bij een studie met verscheidene centra.
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In dit hoofdstuk beschrijven wij een methode waarbij de verschillen tussen personen geschat 
worden in het grote oorspronkelijke onderzoek en de verschillen tussen onderzoekers en centra 
in de kleine reproduceerbaarheidsstudie. Dit wordt beschreven aan de hand van een voorbeeld 
van de huidplooimetingen uit de POPS-19 studie. De methode verandert niet de uitkomst, 
namelijk hoe herhaalbaar de meting is, maar wel hoe betrouwbaar men dit kan schatten. 
Zo worden ook reproduceerbaarheidsstudies efficiënter en hoeven minder proefpersonen 
meerdere keren te worden gemeten. Deze methode wordt hier gedemonstreerd in de POPS-
19 studie, en is overal toepasbaar waar sprake is van een relatieve fout - die meestal gepaard 
gaat met grotere verschillen bij grotere meetwaarden - in plaats van een absolute fout. 
Hoofdstuk 5. Een praktische aanpak voor het toepassen van Bland-and-Altman 
grafieken en Variatie Coëfficiënten op log-getransformeerde variabelen 
Meetfout kan op diverse manieren worden uitgedrukt. Als boven beschreven is het belangrijk 
om een beeld te hebben van de meetfout in de uitkomst van een studie. Eén methode om 
meetfout te beschrijven is door middel van een Bland-and-Altman-grafiek. In deze grafiek 
wordt het verschil tussen twee metingen afgezet tegen het gemiddelde van de twee metingen, 
samen met de grenzen van overeenstemming waarbinnen 95% van de gevonden verschillen 
zich bevindt. Dit is een overzichtelijke, grafische maat voor de herhaalbaarheid van metingen, 
waarbij de onderzoeker of clinicus zelf kan afleiden hoe relevant hij het verschil vindt ten 
opzichte van de gemeten waarde. Deze waarden zijn namelijk direct af te lezen op de beide 
assen van de grafiek.
Als een uitkomstmaat een scheve verdeling heeft, wordt doorgaans een transformatie naar 
een normale verdeling verricht, vaak een log-transformatie. Dit is bijvoorbeeld het geval voor 
de huidplooien gemeten in de POPS-19 studie, waarmee uiteindelijk het vetpercentage van 
de deelnemers is bepaald. Na log-transformatie vervalt echter een groot voordeel van de 
Bland-and-Altman-grafiek, namelijk dat de verschillen en gemiddelden direct afleesbaar zijn 
op de schaal waarop ook klinisch is gemeten. 
In dit hoofdstuk beschrijven wij hoe de grenzen van overeenstemming kunnen worden 
berekend op de logaritmische schaal, met als uitkomst een ratio. Door vervolgens een 
terugtransformatie toe te passen, kunnen deze grenzen van overeenstemming als verschillen 
worden ingetekend in de Bland-and-Altman-grafiek op de oorspronkelijke schaal. Dit 
geeft voor elk getal op de oorspronkelijke schaal aparte grenzen van overeenstemming die 
rechtstreeks kunnen worden afgelezen uit de figuur. Dit wordt geïllustreerd aan de hand van 
de huidplooimetingen uit de POPS-19 studie.
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Een soortgelijke toepassing wordt uitgewerkt voor de Variatie Coefficiënt, een maat voor 
de meetfout waarin de meetfout wordt uitgedrukt ten opzichte van het gemiddelde van 
de meting. Deze maat is nietszeggend indien rechtstreeks toegepast op een logaritmische 
schaal, aangezien hier een absoluut nulpunt ontbreekt. Door het schatten van de standaard 
fout van de log-getransformeerde waarden kan wel een interpreteerbare Variatie Coëfficiënt 
berekend worden. 
Hoofdstuk 6. Groeivertraging in de baarmoeder: geen verbindende onderliggende 
risicofactor voor het ontstaan van het metabool syndroom bij jong volwassenen 
In verscheidene studies is reeds een verband aangetoond tussen vroege groei en het ontstaan 
van het metabool syndroom op volwassen leeftijd. Bij nadere beschouwing blijkt echter dat 
in de meerderheid van deze studies alleen de afzonderlijke componenten van het metabool 
syndroom zijn bestudeerd en niet de gehele uitkomst metabool syndroom volgens de 
internationaal gedefinieerde criteria. Daarnaast wordt geregeld gecorrigeerd voor huidig 
lichaamsgewicht, terwijl (over)gewicht deel is van het metabool syndroom en dus van de 
uitkomstmaat zelf. Dit is dan ook onjuist. 
Daarom beschrijven wij in dit hoofdstuk het verband tussen vroege groei en het ontstaan 
van het metabool syndroom op jong volwassen leeftijd. Als maat voor vroege groei wordt 
het geboortegewicht gecorrigeerd voor de zwangerschapsduur gebruikt, en het metabool 
syndroom wordt gedefinieerd volgens internationale criteria. De onderzoekspopulatie betreft 
de Noorse HUNT-studie; een grootschalig gezondheidsonderzoek waaraan ongeveer 8000 
mannen en vrouwen tussen de 20 en 30 jaar oud deelnamen. Naast de in deze studie 
verkregen gegevens over hun huidige gezondheid, is van alle deelnemers ook een nauwkeurig 
geboortegewicht en zwangerschapsduur bekend uit het Noors nationaal geboorteregister. 
Het metabool syndroom was niet geassocieerd met geboortegewicht binnen de vrouwelijke 
onderzoekspopulatie, terwijl voor de mannen een zwak U-vormig verband werd gezien. Dit 
betekent een licht verhoogd risico op het metabool syndroom zowel voor mannen met een 
lager als een hoger geboortegewicht dan gemiddeld. Bij bestudering van de afzonderlijke 
componenten van het metabool syndroom werden zowel voor mannen als voor vrouwen 
diverse significante verbanden gevonden voor het effect van geboortegewicht, maar in 
tegengestelde richtingen. Deze tegengestelde verbanden voor de diverse componenten van 
het syndroom in relatie tot dezelfde aannemelijke risicofactor - namelijk vroege groei - doen 
de toegevoegde waarde van het concept ‘metabool syndroom’ afnemen. 
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Hoofdstuk 7. Het effect van groeivertraging in de baarmoeder op de nierfunctie op 
jong volwassen leeftijd: de Nord Trøndelag Gezondheisstudie (HUNT 2)
Uit dierstudies en onderzoek bij overledenen is gebleken dat de nier een orgaan is dat erg 
kwetsbaar is voor de nadelige effecten van groeivertraging. Daarnaast is de nierfunctie 
gerelateerd aan het metabool syndroom door regulatie van de bloeddruk door de nier 
enerzijds, en schade aan de nier door suikerziekte en hoge bloeddruk anderzijds. 
De relatie tussen geboortegewicht en nierfunctie op jong volwassen leeftijd is eerder 
onderzocht in de POPS populatie van veel te vroeg geborenen. In dit hoofdstuk beschrijven 
wij het verband tussen geboortegewicht en het ontstaan van een laag-normale nierfunctie 
op jong volwassen leeftijd in de algemene populatie die voornamelijk bestaat uit mensen 
geboren na een voldragen zwangerschap. Dit wordt onderzocht in de Noorse HUNT-studie bij 
ongeveer 8000 mannen en vrouwen van 20 tot 30 jaar. 
Uit dit onderzoek blijkt dat een verlaagd geboortegewicht voor de zwangerschapsduur leidt 
tot een licht verhoogd risico op een laag-normale nierfunctie op jong volwassen leeftijd. Dit 
verband was sterker en eenduidiger voor mannen dan voor vrouwen. 
Hoofdstuk 8. Associaties tussen groei voor en kort na de geboorte en BMI, vetmassa 
en vetverdeling op jong volwassen leeftijd: een prospectieve cohort studie in veel te 
vroeg geboren mannen en vrouwen
Lichaamsgewicht en lichaamssamenstelling vormen mogelijk een belangrijke link tussen 
vroege groei en het ontstaan van hart- en vaatziekten op latere leeftijd. In dit hoofdstuk 
wordt het verband beschreven tussen geboortegewicht, groei in de eerste maanden na de 
geboorte en lichaamsgewicht en lichaamssamenstelling op jong volwassen leeftijd. Dit is 
onderzocht in de POPS-19 studie: een groep van ongeveer 400 19-jarigen geboren na een 
zwangerschapsduur van minder dan 32 weken. 
Normaal gesproken vormt het geboortegewicht een afspiegeling van de totale groei tijdens 
de gehele zwangerschap. In deze specifieke populatie van veel te vroeg geborenen vormt het 
geboortegewicht echter een directe afspiegeling van de groei tijdens de eerste twee trimesters 
van de zwangerschap en kan de groei daarna rechtstreeks in kaart worden gebracht. Zo 
kan tevens het effect van de timing van groeivertraging op volwassen lichaamsgewicht en 
lichaamssamenstelling worden onderzocht. 
Gemiddeld hadden de POPS-19 deelnemers een lager gewicht en een lagere body mass index 
(BMI) dan hun leeftijdsgenoten geboren na een voldragen zwangerschap. Hun gemiddelde 
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huidplooidikte en buikomvang lagen echter hoger dan het populatiegemiddelde. Meer groei 
voor de geboorte was geassocieerd met een groter gewicht, een grotere lengte en een hogere 
BMI op jongvolwassen leeftijd, maar niet met een andere vetmassa of vetverdeling. Meer 
groei kort na de geboorte daarentegen leidde tot zowel een hogere BMI als tot een groter 
percentage lichaamsvet en een grotere buikomvang op 19-jarige leeftijd, gecorrigeerd voor 
het effect van geboortegewicht. 
Hoofdstuk 9. Discussie 
In dit hoofdstuk worden de belangrijkste bevindingen uit dit proefschrift in een breder 
wetenschappelijk kader geplaatst. 
Wij bevestigen in dit proefschrift niet de eerder gevonden associatie tussen een laag 
geboortegewicht en een verhoogde kans op het metabool syndroom op volwassen leeftijd. 
Hiervoor zijn verschillende verklaringen denkbaar. Daarnaast verminderen onze bevindingen 
over de verschillende associaties van geboortegewicht met de afzonderlijke componenten van 
het metabool syndroom de reeds in twijfel getrokken toegevoegde waarde van het concept 
metabool syndroom nog iets meer. 
De resultaten met betrekking tot de associatie tussen verminderde prenatale groei en een 
verhoogde kans op een laagnormale nierfunctie op volwassen leeftijd komen overeen met de 
bestaande literatuur over onderzoek in andere populaties. 
Bij het onderzoek van veel te vroeg geborenen vinden wij evenmin een negatief of U-vormig 
verband tussen geboortegewicht en de kans op een hoger gewicht of ongunstiger 
lichaamssamenstelling op jongvolwassen leeftijd. Dit kan betekenen dat dit verband, 
gevonden in andere studies, pas ontstaat in het derde trimester van de zwangerschap, of 
door methodologische verschillen tussen deze studies en de POPS-19 studie, bijvoorbeeld in 
populatie of in analysemethode. 
Het is moeilijk om de resultaten van de POPS-19 studie te generaliseren naar de huidige 
generatie van veel te vroeg geboren kinderen. Dit wordt vooral veroorzaakt door een groot 
verschil in behandelmogelijkheden tussen toen en nu. Hierdoor overleven meer kinderen en 
daarmee een ander soort kinderen de zeer vroege geboorte. Dit kan een weerslag hebben op 
de mate waarin vroege invloeden doorwerken in het volwassen leven. 
Om openstaande vragen over het metabool syndroom, de timing van de early origins of 
adult disease en de effecten van vroege invloeden in de huidige generatie veel te vroeg 
geborenen te beantwoorden, is verder onderzoek nodig. De methodologische artikelen in 
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dit proefschrift leveren een bijdrage aan dit toekomstig onderzoek door handreikingen te 
bieden voor het maken van een interpreteerbaar regressiemodel en het efficiënt opzetten van 
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